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Abstract
There is substantial evidence to indicate that the Type A 
Behavior Pattern is associated with an increased risk of 
coronary heart disease. Recent research has shown that Type 
As* as canpared to Type Bs, demonstrate enhanced biochemical 
and cardiovascular responses to stressful situations. These 
findings have led researchers to postulate that physiological 
reactivity may be one of the mechanisms through which Type A 
behavior confers coronary risk. The present study was designed 
to investigate physiological and psychological reactivity in 
Type A and Type B cardiac patients exposed to a cardiac 
catheterization. The effects of drugs (i.e., none versus 
beta-blockers and calcium channel blockers) on the response to 
stress was systematically evaluated. Dependent measures, 
adrenocorticotropic hormone (ACTH), systolic blood pressure 
(SBP), diastolic blood pressure (DBP), heart rate (HR), state 
anxiety (STAI-state), and Total Mood Disturbance (TMD), were 
obtained prior to cardiac catheterization (day 1) and 24 hours 
later (day 2). A 2 x 2 x 2 (Behavior Type x Drug Group x Day) 
analysis of variance with repeated measures on day revealed 
significant main effects of day for ACTH, SBP, and state 
anxiety. A significant main effect for drug group and a 
significant Behavior Type x Drug interaction was revealed for 
ACTH. A significant Behavior Type x Day interaction was found 
for SBP. An additional analysis investigating the responses of
ix
extreme Type A and Type B subjects revealed significant main 
effects of day for HR and State Anxiety. The results of the 
present study failed to support previous research 
demonstrating that Type A subjects, as carpared to Type B 
subjects, exhibit exaggerated responsivity to stress. Possible 
reasons for this failure to find significant A-B differences 
are explored. The major contribution of the present study was 
the finding, consistent with previous research, that the target 
medications were associated with substantially reduced 
responsivity to stress (as measured by ACTH) in Type A cardiac 
patients to levels consistent with the response of Type b 
cardiac paients. The clinical and research implications 
arising from this finding are discussed. Continued systematic 
evaluation of the effects of medications on reactivity is 
strongly recommended.
CHAPTER ONE
Cardiovascular disease is the leading cause of death in the 
United States today. More than 43 million Americans have seme 
form of this disease. Almost five million Americans suffer fran 
coronary heart disease (CHD), a form of cardiovascular disease 
(American Heart Association, 1985). Among the cardiovascular 
diseases, heart attacks, one of the manifestations of CHD, are the 
leading cause of death, accounting for 554,900 deaths in 1982 
(American Heart Association, 1985). Cost to the national economy 
in 1985 has been estimated at 72.1 billion dollars, including 
costs for hospitalisation, physician and nursing services, 
medications, and disability costs (American Heart Association, 
1985). Cardiovascular disease ranks second to respiratory 
diseases with respect to days of bed disability and first among 
diseases that limit activity and cause the greatest number of 
hospital bed days (Levy, 1982). Recent trends in medicine and 
technology, and increasing public awareness, have resulted in sane 
decline in cardiovascular mortality. Despite this, however, 
cardiovascular disease remains a problem of significant 
proportions (Levy, 1982).
Research examining the participation of behavioral risk 
factors involved in CHD has witnessed growing interest (Eliot, 
Buell, & Dembroski, 1982) especially because of the evidence from 
studies indicating that behavioral risk factors are significantly 
related to CHD (Rosenman, Friedman, Straus, WUrm, Kositchek, Hahn, 
6 Werthessen, 1964; Haynes, Feinleib, & Kannel, 1980). There is
1
2now a substantial body of literature demonstrating the Type A 
Behavior Pattern (Friedman 6 Rosenman, 1959), characterized 
primarily by a sense of time urgency, easily aroused hostility, 
and competitive achievement striving, is strongly associated with 
incidence, and often severity of CHD.
Coronary Heart Disease
Coronary heart disease (CHD) is a clinical term used to 
describe that group of cardiovascular diseases in which the 
primary symptomatic manifestations are angina pectoris (i.e., 
chest pain secondary to an oxygen defiency in a region or regions 
of the heart), myocardial infarction (i.e., a consequence of 
coronary artery disease in which irreversible cellular injury and 
necrosis occurs secondary to prolonged ischemia), and sudden 
cardiac death. Sudden cardiac death is defined as unexpected, 
witnessed death in a subject with or without preexisting heart 
disease, who dies in less than one hour following the terminal 
event (Kloster & Bristow, 1985). The major etiologic cause of CHD 
is atherosclerosis, an accumulation of fatty deposits in the 
coronary arteries that restricts blood flew (Willerson, 1982). 
Arteries are blood vessels that flow away from the heart and carry 
oxygenated blood to various parts of the body. The coronary 
arteries are those which directly provide oxygen and nourishment 
to the heart itself. The process of atherosclerosis will be 
considered in subsequent sections of this paper.
A long list of major and minor cardiovascular risk factors 
have been described from epidemiological studies. According to
3Levy (1982), the major risk factors are age, sex, hypertension, 
cigarette smoking, diabetes, high levels of low density 
lipoproteins, and deficit levels of high density lipoproteins.
Lew density lipoproteins (LDL) are the major carriers of 
cholesterol. There is a positive association between high levels 
of LDL and CHD. High density lipoproteins (HDL) provide a 
protective effect that is as yet not clearly understood. The HDL 
level is inversely related to cardiovascular risk (i.e., the 
higher the HDL, the lower the cardiovascular risk).
Hyperlipidemia, defined as serum cholesterol and/or triglycerides 
at levels higher than the 95th percentile for controls, is thought 
to be a major risk factor for atherosclerosis. A number of mjnor 
risk factors have also been reported. These are family history of 
heart disease, obesity, sedentary lifestyle (or lack of regular 
physical activity), and emotional stress (including personality 
type).
Aside frcm physical examination, several diagnostic 
procedures (e.g., chest x-ray, electrocardiography, 
echocardiography, cardiac catheterization) are available to the 
physician interested in evaluating cardiac function. The 
following discussion focuses on cardiac catheterization, because 
this is the procedure used in the present study. Cardiac 
catheterization (also known as coronary arteriography or coronary 
arteriogram) is a powerful diagnostic procedure that allows for 
comprehensive assessment of cardiac structure and function. It 
involves the detailed measurement of intracardiac, pressures and
4blood flow and the angiographic visualization of heart and 
coronary arteries (Harrison, 1982). A cardiac catheteterization 
is employed when cardiac condition cannot be adequately 
established through history, physical ex an, or the use of 
noninvasive techniques. It can serve primarily as a method for 
providing the anatomic and physiologic details necessary for 
planning surgery (e.g., coronary artery bypass surgery). It can 
be used to evaluate the severity of a known cardiovascular 
disorder in which there is a discrepancy between syrptcms and 
physical findings. It can also be employed as a diagnostic 
procedure in the assessment of suspected cardiovascular disease or 
to clarify the presence of symptoms with unknown etiology. In the 
patient who ccnplaihs of recurrent chest pain consistent with 
angina pectoris, the cardiac catheterization is a necessary and 
invaluable technique for establishing the presence of coronary 
artery disease (Wallace, 1982). It is currently the most reliable 
diagnostic test to detect the presence of coronary 
atherosclerosis.
Medical Management of CHD
Over the past two decades, remarkable advances have been made 
in the management of angina pectoris. Pharmacologically, three 
major classes of drugs have radically changed the medical 
treatment of angina (Kloster & Bristcw, 1985). These are: (a)
the nitroglycerin (NIG) preparations and related nitrates, (b) the 
beta-adrenergic blocking drugs, and (c) the calcium entry blocking 
drugs. These drugs, alone or in combination, are reported to be
5highly, effective in preventing or relieving chest pain in CHD 
patients. There is seme evidence to suggest that they may reduce 
CHD mortality and other complications of coronary atherosclerosis 
(Kloster et al., 1985). Each of these drugs is described briefly 
in the following section. Unless otherwise noted, the majority of 
the following information is taken from two sources—  Kloster et 
al (1985) and McCall, Walsh, Frolich, & O'Rourke (1985).
Nitrates. The use of nitrates was introduced 100 years ago 
as antianginal agents. Today they remain the mainstay for 
treatment of angina. These drugs owe much success to their rapid 
onset of action with subsequent prompt and complete relief of 
pain. A number of preparations are available including oral, 
transdermal, and sublingual forms. Although the physiological 
consequences are not completely understood, it appears that the 
main sites of action are the specific receptor sites in vessel 
walls that produce dilation of vascular and other smooth muscle 
throughout the body. The most potent effects are on the venous 
system, with lesser effects on the large arteries. The effects of
nitrates on the peripheral veins, the systemic arteries, and the
*
coronary circulation, contribute to the beneficial responses of 
decreased myocardial oxygen demand and improved myocardial 
perfusion.
Beta-adrenoreceptor blocking drugs. Beta-adrenoreceptor 
blocking drugs are among the most widely prescribed medications. 
These drugs, also known as beta antagonists, are competitive 
inhibitors of catecholamine binding at beta-adrenergic sites.
6thereby blocking or decreasing the effects of catecholamines. The 
mechanisms of action and the efficacy of these drugs are more 
clearly understood than is the case for nitrates. According to 
their sites of action, two types of beta-blockers have been 
identified. Beta-1 drugs block cardiostimulation and lipolysis. 
Beta-2 blockers block vasodilation. The cardiac effects of beta-1 
antagonists result in decreased heart rate and decreased 
myocardial contractility as do all beta blockers. They do differ 
in terms of their non-cardiac effects on beta-2 receptors in the 
peripheral circulation and in the bronchi, this selectivity, 
though, is relative because at higher doses, both receptors are 
blocked (Durel, Krantz, Bisold, & Lazar, 1965). Although 
beta-antagonists do vary in terms of potency, this is clinically 
unimportant because dosages are titrated. By decreasing heart 
rate and contractility, beta blockers reduce myocardial oxygen 
demand, and decrease systemic arterial blood pressure and cardiac 
output. Systemic vascular resistance is increased.
Beta-antagonists also differ, aside frcm their cardioselectivity, 
in other ways as well. Seme (e.g., prcpanolol) have a 
quinidine-1 ike effect making them useful in the treatment of 
arrhythmias. Beta-antagonists differ with respect to solubility 
with sane being lipid soluble and seme being water soluble.
Although differences do exist, there does not appear to be 
any particular advantages or disadvantages associated with any of 
them. They have been reported to be equally effective, resulting 
in symptomatic relief in .80 per cent of patients. Another drug
7may be chosen, however, when certain contraindications exist 
(e.g.., congestive heart failure, obstructive airway disease, or 
diabetes) or when potentially harmful side effects are anticipated 
(e.g., bradycardia). They are often used in combinations with 
nitrates or calcium entry blockers.
Calcium entry blockers. These drugs represent a 
heterogenous group sharing in cannon the ability to inhibit the 
movement of calcium ions across myocardial and vascular smooth 
muscle. Three are currently approved for use in the United 
States, nifedipine, verapamil, and diltiazem, for the management 
of chronic stable angina in patients intolerant (secondary to side 
effects or contraindications) or refractory to treatment with 
beta-blockers and nitrates. Calcium entry blockers are also used 
to manage coronary artery spasm (a variant of angina). They are 
reported to be at least as effective as beta-antagonists and 
nitrates. The mechanism of action appears to be a decrease of or 
inhibition of calcium into the interior of the cell, and thus they 
modify a number of calcium-dependent processes (e.g., 
excitation-con traction in vascular smooth muscle). The direct 
cardiovascular effects are qualitatively similar resulting in 
decreased force of contraction, dilation of the coronary and 
systemic arteries, and slowed heart rate. All three also reduce 
systemic arterial pressure and vascular resistance, thus 
decreasing myocardial oxygen demand.
The Type A Behavior pattern
The role of psychosocial factors in cardiovascular disease
8was first empirically studied by two cardiologists, Friedman and 
Rosenman. Their research, which began in the 1950s, resulted in 
the formulation of the Type A behavior pattern (TABP). The TABP 
is best characterized as a set of overt behaviors which can be 
elicited from susceptible individuals given appropriately 
challenging environments (Matthews, 1982). The central elements 
of the behavior pattern appear to be a sense of time urgency, 
easily aroused hostility, and competitive achievement striving. 
Type A, which has been termed the "new" risk factor for CHD 
(Price, 1982), has been demonstrated in several epidemiological 
studies to be independently associated with an increased incidence 
of heart disease (Rosenman et al., 1964; Haynes, Levine, Scotch, 
Feinleib, & Kannel, 1978). The findings of such research, 
together with the emergence of the field of behavioral medicine 
and the need for a preventive approach to CHD, has resulted in a 
recently renewed interest in Type A behavior. This is reflected, 
in part, by the fact that, of all Type A studies published since 
1959, greater than half have appeared in the last five years 
(Price, 1982).
Epidemiological Studies
As mentioned, the work of cardiologists, Friedman and 
Rosenman (1959), set the stage for empirical evaluation of the 
role of stress in cardiovascular disease. Frustrated by the 
inability of traditional risk factors, or combinations of these 
risk factors, to predict more than half of the new cases of CVD, 
these cardiologists began to observe their cardiac patients for
9caramon emotional characteristics. Over twenty years of study 
resulted in the following definition of Type A Behavior:
"A characteristic action-emotion complex which is 
exhibited by those individuals who are engaged in a 
relatively chronic struggle to obtain an unlimited
number of poorly-defined things from the environment in
»
the shortest period of time, and, if necessary, against 
the opposing efforts of other things or persons in the 
same environment" (Friedman & Rosenman, 1974, p. 67). 
Persons without this style of behavior, who instead maintain a 
more relaxed, unhurried lifestyle, are described as Type B 
individuals. The Type B behavior pattern is often thought of as 
being the antithesis of Type A. This is probably not an accurate 
characterization because the Type B individual may possess sane 
Type A behaviors, but not to the exaggerated degree that a Type A 
will shew them. Matthews (1982) notes that the exact 
constituients of Type b behavior remains a matter of controversy. 
In her review of the Type A literature, she concludes that Type A 
is not a trait or a discrete typology but is instead thought to 
occur on a continuum ranging fran extreme Type A to extreme Type 
B.
Friedman and Roserman (1959) characterized Type A by the 
following: "1) an intense, sustained drive to achieve
self-selected but usually poorly defined goals, 2) a profound 
inclination and eagerness to ccnpete, 3) a persistent drive for 
recognition and advancement, 4) a continuous involvement in
10
multiple and diverse functions constantly subject to time 
restrictions (deadlines), 5) a habitual propensity to accelerate 
the rate of execution of many physical and mental functions, and 
6) an extraordinary mental and physical alertness" (p. 1286).
The initial research efforts of Friedman and Roserman began 
with investigations of possible biochemical correlates that might 
acccnpany the TABP* Friedman, Roserman, and Carroll (1958) 
studied 40 male accountants before, during, and after periods of 
increased occupational stress. Type A behavior was assessed using 
a personal interview which later became the Stuctured Interview 
(Friedman et al., 1964). Their results indicated that exposure to 
a stressful situation led to a marked rise in serum cholesterol 
and an acceleration of blood coagulation that was independent of 
diet and physical activity.
Friedman et al. (1959) randanly selected three groups of men, 
reported to differ only with respect to behavior pattern, from 
various occupational levels to further study the results 
previously found with the accountants. Three groups were formed. 
Type A, B, and C, and compared with respect to serum cholesterol, 
blood clotting time, presence of clinical coronary disease, and 
presence of arcus senilis. Arcus senilis is a term referring to 
the presence of a gray opaque ring surrounding the margin of the 
cornea and resulting fran lipoid degeneration (Borland, 1982).
The Type C group was similar in behavior to the Type B group but 
Group C also showed chronic anxiety. Results suggested an 
overwhelming difference between the groups of men with respect to
11
Incidence of heart disease. Men in group A (fully developed Type 
A) were found to be seven times more likely to have clinical 
artery disease than men fran Groups B or C. Group A was also 
reported to show significantly higher serum cholesterol levels, 
faster clotting times, and three times the incidence of arcus 
senilis. These authors reported that these results were not 
attributable to differences in exercise, fat intake, alcohol, or 
cigarettes. They concluded that it was likely that the behavior 
pattern accounted for the differences in the dependent variables.
In a new classic prospective study, the Western Collaborative 
Group Study (WOGS), Roserman, Friedman, Straus, WUrm, Kositchek, 
Hahn, and Werthessen (1964, 1975) examined the predictive 
relationship between TABP and CHD. These authors hypothesized 
that if the behavior pattern plays a significant role in 
accelerating CHD, then healthy men, without CHD, with this 
behavior pattern, should show a higher future incidence of CHD. 
Subjects were 3,154 employed males, aged 39 to 59 years, recruited 
from ten business organizations in California. Overt behavior 
pattern was assessed using a personal interview, the Structured 
Interview. This interview contained 27 items requiring subjective 
interpretation by the examiner. There were six content areas 
included in the interview: (a) history of past social
achievements, (b) present drive to achieve, (c) competitive 
involvement, (d) time urgency, (e) hostility, and (f) overt 
stylistic signs of TABP ( e.g., appearance of urgency, gesturing, 
explosive speech). TABP was observed in 1,589 of the men, and
12
Type B behavior was determined in 1,565 of the men. A thorough 
history (e.g., history of illness, family history, education, 
occupation, physical activity, diet, alcohol, and tobacco use, 
etc.) was obtained and dependent variables— serum lipid and 
lipoprotein studies, blood coagulation studies, and cardiovascular 
examination— were collected at intake and annually for eight to 
nine years. Results at follow up indicated that Type As were 
twice as likely to develop CHD than Type B subjects. In addition, 
Type As, as compared to Bs, were found to have: (a) five times
the frequency of suffering a second myocardial infarction (MI),
(b) twice the frequency of fatal Mis, (c) twice the degree of 
coronary atherosclerosis at post mortem examination in the 25 
patients who died. Eighty-eight per cent, or 22 of 25, of the 
subjects who died of CHD were assessed at intake as Type A. 
Rosenman et al. (1975) reported that this predictive association 
between Type A and CHD was not attributable to traditional risk 
factors. These authors suggested that the TABP should be 
considered prominent among the major risk factors for CVD. They 
emphasized that Type A was not an artifact of other risk factors 
and that the pathogenic force of the behavior pattern was not due 
to other risk factors. They speculated that the danger associated 
with Type A behavior might operate through neurohumoral 
mechanisms.
Twenty-five of the subjects from the WCGS, were later found 
to show that evidence of a "silent MI" (by electrocardiography) 
that was unknown to the subjects or the WCGS investigators at the
13
time of data collection. Jenkins (1966), with the cooperation of 
Friedman and Bosenman, designed a study intended to objectify the 
components of TABP and to examine the behavioral and biochemical 
attributes of these men identified as having suffered from "silent 
Mis". Two control groups were used; (a) a group matched for age 
and occupation, and (b) a group matched on age, occupation, and 
behavior (A or B). Both control groups were found to be free of 
any signs of CHD. As in the original VJCGS, the scores of the six 
behavior components and biochemical data were analyzed. Regarding 
behavior type, it was found that the scores from the "silent 
infarct" subjects were significantly higher than the control group 
scores on record of past achievements, manifest hostility, and 
total score. Further, the men in the "silent infarct" group who 
scored high on impatience and time urgency also had a history of 
higher achievement with regard to job status. With respect to 
blood lipid measures, it was reported that subjects with high 
levels of hostility showed significantly higher mean serum beta 
lipoprotein and beta-alpha lipoprotein ratios. High scores on the 
achievement component were associated with higher total serum 
cholesterol levels. This data led Jenkins (1966) to suggest that, 
perhaps, the TABP was not a unidimensional construct, but instead 
that various combinations of traits were associated with various 
biochemical variables. The work of Jenkins (1966) lends support 
to the findings of the WCGS and also emphasizes the need for a 
more objective approach.
Another classic epidemiologic study in the area of Type A
14
research was conducted by Haynes et al. (1978, 1980) with the 
Framingham Heart Study. Using 1822 men and wcmen of the 
Framingham cohort, aged 45-77, these authors investigated the role 
of psychosocial stress in the etiology of blood pressure, serum 
cholesterol, and smoking. Subjects were free of clinical symptoms 
of CHD at the initiation of the study. They were followed 
annually for a period of eight years. In a three part series of 
publications resulting from this study, Haynes et al. (1978a, 
1978b, 1980) describe the development of the Framingham Type A 
Psychosocial Interview and report correlational data on a variety 
of psychosocial factors and CHD, including the association between 
psychosocial stress and CHD risk at eight year follow-up. The 
interview developed by these authors included 20 scales that can 
be grouped into four main catagories: (a) Behavior
types— including Framingham Type A Behavior, emotional lability, 
anbitiousness, and non-easy going scales, (b) situational 
Stress— including scales measuring situations from job, marriage, 
and life, (c) Somatic strains— including measures of tension, 
daily stress, anxiety, and anger, and (d) Sociocultural mobility 
including scales measuring occupational changes, promotions, 
educational, and job mobility.
Results revealed that the Framingham Type A Behavior Scale 
was correlated with anbitiousness, emotional lability, tension, 
daily stress, anger symptoms, educational level, and occupational 
status. Sex differences were observed, with women being less 
likely to exhibit the Framingham Type A behavior but showing more
15
signs of emotional lability, anger, tension, and anxiety. Less 
consistent differences were found between measures of psychosocial 
stress and blood pressure or cholesterol. There was no associaton 
found between scores on the Framingham Type A Behavior Scale and 
standard CHD risk factors.
At follow-up (eighth or ninth biennial exam), the data 
revealed that subjects with all four categories of CHD (i.e., 
uncomplicated angina, angina with or without MI, MI, and total 
CHD) scored higher than did subjects without CHD manifestations.
In a multivariate analysis, the Framingham Type A Behavior Scale 
differentiated between men with and without MI even when 
traditional risk factors were controlled. The degree of coronary 
risk associated with the Type A behavior for men 39-59 was 2.2 for 
total CHD, 2.1 for MI, and 2.5 for angina pectoris only. Coronary 
risk for men aged 45-64 was found to be lowert 1.8 for total CHD, 
2.1 for MI, and 1.8 for angina. It is noteworthy that this 
association was significant only among men having white-collar 
jobs. The differences between Type A and Type B disappeared when 
blue-collar workers were studied. When other psychosocial stress 
scales were included in the analysis, a scale reflecting aging 
worries was found to be the only significant discriminator. Among 
the women, both the Framingham Type A Behavior Scale and the 
emotional lability scales were correlated with CHD prevalence when 
other risk factors were controlled. The coronary risk associated 
with Type A behavior in women (under 65) was found to be 2.1. 
Further, suppressed hostility was found to be an independent
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predictor of CHD among white-collar men and working women.
In conclusion, the work of Haynes et al. (1978a. 1978b, 1980) 
supports previous data indicating that Type a  behavior is 
associated with increased coronary risk, despite the use in this 
study of an alternative method for assessing Type A. However, in 
the Framingham study, only white-collar men and employed women 
were found to have a significant association between TABP and 
increased coronary risk. The importance of hostility as a 
contributing factor was also demonstrated in this study.
Brand, Roserman, Sholtz, and Friedman (1976) compared the
, t
results of the WCGS and the Framingham study using a multiple 
logistic method of analysis. After adjusting for length of 
follow-up, these authors concluded that the CHD risk predictions 
from both studies demonstrated good agreement. They foupd that 
the relative risk of CHD (obtained from estimated logistic 
coefficients for behavior pattern) was 1.90 and 2.10 for younger 
and older decades, respectively. That is, after traditional risk 
factors were adjusted, younger Type A men (aged 39-49) had 1.90 
times the risk far CHD than Type B men. Older men (aged 50-59) 
showed 2.10 times the risk of CHD when compared to Type B men in 
the same age category. Brand et al. (1976) also investigated what 
CHD reduction would occur if the direct risk associated with TABP 
was eliminated. They found that for the younger group, a 28.5 per 
cent risk reduction would occur. A 32.3 per cent reduction was 
reported for the older group. Combining these groups resulted in 
a 31 per cent risk reduction rate.
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Disconfirming results on the association between CHD and Type 
A behavior have been published. One recent study (Case, Heller, 
Case, & Moss, 1985) reported that Type A (assessed using the JAS) 
was not related to cardiac mortality or other disease indices 
(e.g., left ventricular ejection fraction) in 516 post-infarct 
subjects. Given this data, sane researchers have argued that the 
JAS does not accurately assess Type A. However, other sources of 
error are equally likely, previous research (Rosenman et al., 
1964) has indicated that Type A individuals are more at risk of 
dying from heart attacks. It is possible, then, that subject 
mortality resulted in a biased sanple in this study. Secondly, it 
is conceivable that the experience of having a heart attack might 
lead same patients to change their behavior. At any rate, 
negative findings fron one study, that stand in direct contrast to 
a substantial number of studies demonstrating positive findings, 
do not automatically negate the association between Type A and 
CHD. Instead, the findings of Case et al. (1985) should serve as 
an impetus for continued research.
In 1981, the results of the Review Panel on Coronary-Prone 
Behavior and Coronary Heart Disease, sponsored by the National 
Heart, Blood, and Lung Institute, were published. This panel 
consisted of bianedical and behavioral scientists whose task was 
to critically evaluate the existing scientific knowledge on the 
proposed association between behavior and CHD. After an extensive 
review of the literature, these panel members concluded:
"The review panel accepts the available body of
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scientific evidence as demonstrating that type A 
behavior-as defined by the structured interview..., the 
Jenkins Activity Survey .... and the Framingham type A 
behavior scale-is associated with an increased risk of 
clinically apparent CHD in employed, middle-aged U.S. 
citizens. This risk is greater than that imposed by 
age, elevated values of systolic blood pressure and 
serum cholesterol, and smoking, and appears to be of the 
same order of magnitude as the relative risk associated 
with the latter three of these factors" (p. 1200).
Assessment of Type A Behavior
The two most commonly used methods for assessing Type A 
behavior are the Structured Inverview (SI, Rosenman et al., 1964) 
and the Jenkins Activity Survey (JAS, Jenkins, Rosenman, & 
Friedman, 1967). Both of these measures have been shown in 
numerous studies to discriminate CHD subjects from non-CHD 
subjects and to predict future incidence of CHD in subjects who 
were initially well. The Framingham Type A Behavior Scale (Haynes 
et al., 1978, 1980) has also been found to have these properties, 
but aside from the Framingham Heart Study, it has not been widely 
used. Other Type A measures have also been developed (e.g., 
Bortner Rating Scale, Bortner, 1969) but, as yet, these measures 
have not been shown to have a predictive association with CHD.
Structured interview . The SI (Rosenman et al., 1964) is a 
25 item provocative interview situation in which Type A assessment
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is based on the voice stylistics, psychanotor behaviors, and 
verbal content of the respondent (Roserman, 1978). It was 
developed at the Harold Brunn Institute in San Francisco, 
California for use in the Western Collaborative Group Study 
(WOGS). It is best characterized as a challenge situation in 
which a trained interviewer/observer, attempts to bring out covert 
Type A behaviors (Rosenman, 1978). Sane of the questions are 
dependent solely on verbal content of the response (e.g.,"Do you 
think you drive harder to accomplish things than most of your 
associates?"), other questions are asked in such a way as to 
elicit Type A behavior. For example, the interviewer asks the 
subject a question in a deliberately slew, hesitant fashion, 
anticipating the Type A subject to became annoyed and/or interrupt 
the interviewer. Subjective assessment is then made based on the 
presence of observed motor and verbal stylistics thought to 
characterize the Type A individual (e.g., rapid, loud, emphatic 
speech; frequent use of gestures; frequent interruptions of the 
interviewer). Four assessment catagories are used: (a) Fully
developed Type A (A-l), (b) Incompletely developed Type A (A-2),
(c) Absence of Type A (Type B), and (d) Type X in which 
catagorization is not possible secondary to an equal 
representation of both Type A and Type B.
An 80 per cent test-retest agreement rate has been reported 
for the SI. Interrater reliability estimates range from .75 to 
.90 (Rosenman, 1978). The validity of the SI has been well 
documented as subsequent sections of this paper will
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illustrate.
Jenkins Activity Survey The SI, although shown to be 
reliable and valid, is not necessarily the ideal method for the 
assessment of Type A Behavior. it is not truly objective and does 
not allow for numerical quantification (Roserman, 1978). It 
requires specialized training, supervised experience, and periodic 
quality control in the form of monitoring recorded interviews so 
that observer bias can be prevented (Jenkins, 1978). some authors 
have noted that it may have limited applicability to some 
practitioners because of these factors and the fact that findings 
may be largely dependent on the interviewers' skill (Jenkins, 
Friedman, & Roeerman, 1967). The Jenkins Activity Survey (JAS, 
Jenkins et al., 1967) was developed to duplicate the SI 
psychometrically with the aim of providing a more standard, 
objective approach to the assessment of Type A behavior.
The JAS (Form C) is a self-report, machine-scorable 
questionnaire. It uses a multiple choice response format 
requiring the repondent to choose which response is most true. An 
Overall Type A score is derived along with three factor 
scores— Speed and Impatience (Factor S), Job Involvement (Factor 
J), and Hard-Driving and Competitive (Factor H).
As mentioned, the JAS was developed to duplicate the SI. 
Jenkins worked closely with Friedman and Roserman learning the SI 
and observing many SI assessments. Frcm this, he developed an 
original item pool of 64 questions. Instead of relying on the face 
validity of the 64 original items, the JAS was subjected to a
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series of empirical analyses using subjects and data originally 
collected for the WCGS. In 1964, the experimental version of the 
JAS was administered to 120 men in the WCGS whose behavior pattern 
had been originally assessed using the SI. Forty items of the 
exprimental JAS significantly discriminated between Si-determined 
Type As and Type Bs. These 40 items, along with an additional 21 
items, comprised the first edition of the JAS (Jenkins, Rosenman,
& Zyzanski, 1965). This version was empirically validated using 
2,951 men of the WCGS assessed by the SI as Type A or Type B at 
test (1960) and retest two years later. These men were divided 
into three goups: (a) 400 Type As and 307 Type Bs, (b) 475 Type
As and 509 Type Bs, and (c) an independent sample of 409 men.
The responses of Group 1 were used to scale items and weight 
response alternatives so that weighted scores could be treated as 
a continuous variable on an approximately equal interval scale and 
so that there would be a maximum distinction between criterion 
groups. Group 2 served as a cross-validation sample using 
weighted response items which significantly discriminated between 
As and Bs in group 1. A discriminant function analysis (using 31, 
28, 24, and 19 items) was applied to the items surviving this 
cross-validation in order to compare for item sensitivity and 
specificity with respect to the identification of Type A behavior. 
The 19 item equation was found to be the best predictor of Type A 
behavior. These 19 items were retained and cross-validated using 
group 3.
An approximately normal distribution was found with the
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scores of all 2,951 men tested. Scores were transformed to yield 
a mean of 0.00 and a standard deviation of 10.0. Subjects scoring 
greater than or less than one standard deviation from the mean 
were found to be correctly classified as Type A or Type B by both 
the SI and the JAS. The intermediate scores were found to be less 
accurate for predicting Type A behavior. The level of agreement 
between the 1965 JAS and the 1960 and 1962 SI was determined using 
the third group. A 73 per cent agreement rate was found. Using 
only extreme scores (i.e., greater than or less than one standard 
deviation frcm the mean) resulted in a 90 per cent agreement rate 
(Jenkins, Zyzanski, & Rosenman, 1971). Jenkins et al. (1979) 
reported these to reflect respectable levels of agreement 
considering the change in mode of data collection and the fact 
that three years had elapsed since the most recent SI.
A second edition of the JAS was published in 1966. Redundant 
items or items with less than adequate psychometric properties 
were dropped for this edition and several new items were added. 
This 57-item version was then validated and cross-validated in 
much the same way as was done with the 1965 version. Twenty-six 
items were found to discriminate between Type A and Type B men. 
Some of these items were the same as were found with the 1965 
version, although a number of new items emerged. Cross-validation 
procedures revealed a 71 per cent agreement rate between the 1966 
JAS and the 1960 and 1962 SI.
In order to address the question of whether Type A behavior 
was a single syndrome or an aggregation of subsyndrcmes, a series
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of factor analytic procedures were conducted. Using the data 
obtained from the 1965 and 1966 JAS validation studies, three 
factors were identified (Zyzanski & Jenkins. 1970). These were 
labeled as Factor S (Speed and Impatience), Factor J (Job 
Involvement), and Factor H (Hard-Driving and Competitive).
Jenkins et al. (1979) described the three factors in the following 
ways. Factor S refers to a perceived sense of time urgency. 
Subjects scoring high on this factor tend to be inpatient with 
others, are likely to hurry others along, and are prone to 
irritability. Subjects scoring high on Factor J tend to show high 
levels of dedication to their job. They sure likely to work longer 
hours, to take work heme with them, and report often being 
confronted with deadlines on the job. High scores on Factor H are 
found in individuals who perceive themselves as being serious, 
competitive, and hard-working, often feeling as though they put in 
much more effort than their collegues.
Another version of the JAS was published in 1969. On this 
occasion, the authors felt that the SI from nine years previous 
would be unsuitable to use as validation criteria. Instead, the 
1965 and 1966 editions of the JAS were used. A discriminant 
function analysis was conducted to ascertain the items making the 
strongest contribution to each of the four scales.
A fourth revision (Form B) was then published in 1972 which 
contained those items shown to discriminate between As and Bs in 
the 1969 validation and two new items. Items containing gender 
references were also reworded, making the JAS equally applicable
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to females as well as males.
The nest recent version, Form C, was used in the present 
study. The two experimental items added in Form B were not 
included in Form C as they did not load on any of the four JAS 
scales. Form C, then, contains 52 items. The item composition 
and scoring algorithms in Form C are exactly the same as those in 
the 1969 edition and Form B. Therefore, all psychometric data 
reported in the JAS Manual (Jenkins et al., 1979) for the 1969 
edition and Form B apply equally to Form C.
Jenkins et al. (1979) provides normative data based on the 
1969 JAS scores of 2,588 males employed in middle- and 
upper-echelon jobs who served as subjects in the WCGS. Norms on 
populations other than this (predominantly males) are also 
available.
Measures of reliability of the JAS have been reported. 
Test-retest correlation coefficients, using intervals of one to 
four years, were found to range from 0.60 to 0.70. These 
correlations were found despite modifications in the successive 
editions of the JAS, suggesting that the traits measured by this 
instrument are relatively stable for at least up to a four year 
period. Internal consistency, the degree to which items in a 
scale measure a unified concept, has also been computed. These 
reliability coefficients for all four JAS scales range from 0.73 
to 0.85.
The validity of the JAS has been well documented. Subsequent 
sections of this paper will report findings indicating that the
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JAS predicts CHD incidence and severity of atherosclerosis. As 
has been previously mentioned, rates of agreement between the JAS 
and the SI range fron 73 to 90 per cent, depending on whether 
extreme classifications are used.
Type A and Stress
In light of a growing wealth of evidence indicating the 
significant role of Type A behavior in CHD, many researchers have 
turned their attention toward investigations aimed at assessing 
the possible underlying physiologic mechanisms. Research, thus 
far, has suggested that physiologic responsiveness (i.e., 
reactivity) to emotional stress may be a marker of correlated 
pathogenic processess in CHD or might serve as direct contributors 
to CHD pathology (Krantz & Manuck, 1982). Although many 
individual difference variables are involved in the cardiovascular 
and endocrine response to stress (Krantz et al., 1982), research 
by Eliot (1982) and others suggests that seme individuals show 
exaggerated cardiovascular responses to challenge situations that 
may make them coronary-prone. Results from numerous human and 
animal studies (Manuck, Kaplan, & Clarkson, 1983) support this 
notion, and suggest that pathogenic states can be evoked, even 
with short term exposure to psychological stressors (Krantz et 
al., 1982).
Reactivity involves the measurement of changes from baseline 
functioning that result from exposure to a laboratory or 
naturalistic challenge. If acute changes, produced by psychologic 
stimuli, can be linked to potentially pathogenic states, then
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these responses may serve as more useful predictors than
traditional risk factors that are usually obtained at rest (Krantz
et al., 1982).
Atherosclerosis
Before continuing with a thorough discussion of reactivity,
it may be useful to briefly review the atherosclerotic process in
which most of the coronary artery lesions that result in CHD can
be classified (Wissler,1985). Atherosclerosis can be defined as a
form of arteriosclerosis (i.e., thickening in the walls of the
arterioles) in which lipid filled atheronas (i.e. plagues) form
within the intima and inner media of large and medium sized
arteries (Dorland, 1982). Of uppermost concern here are those
plagues that form within the walls of the coronary arteries. It
is beyond the scope of the present paper to review the various
etiologies proposed for atherosclerosis. The interested reader is
referred to Wissler (1985). Suffice it to say that one of the
ways that these changes can be brought about is by hemodynamic or
chemical injury (Eliot, 1982). Hemodynamic injury results frcm
impaired blood flow or turbulence at the site of the lesion.
Chemically, it is also kncwn that certain blood lipids (e.g. low
density lipoproteins as well as cortisol and catecholamines) at
certain levels are toxic to coronary arteries, and thus, can
accelerate the atherosclerotic process and/or prevent normal
healing (Eliot, 1982). Further, plagues can continue to grow in
*
size secondary to continued lipid and cholesterol deposits, as 
well as from the entrance of blood platelets which are released.
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The end result can be arterial stenosis (which can further 
restrict blood flow), calcification, arterial spasms (responsible 
for seme angina attacks), or worse, ulceration and thrombus (i.e., 
clot) formation. It is the latter event, the development of a 
coronary thrombus, that usually leads to a classical myocardial 
infarction (Wissler, 1982).
There is evidence to suggest that Type A persons show 
elevated blood pressure, heart rate, catecholamines, ACTH, 
cortisol, and serum cholesterol when confronted with appropriate 
challenges (Krantz et al., 1982). Thus, theories relating to the 
sypathetic-adrenal-medullary and pituitary-adrenal-cortical 
systems are the pathways through which behaviorally mediated risk 
mechanisms may operate (Eliot, 1982). The catecholamine surges 
resulting from sympathetic nervous system activation can have as 
consequences the promotion of platelet adhesiveness and 
aggregation, arrhythmias, as well as the secretion of a number of 
hormones, and a decrease in insulin secretion (Eliot, 1982). 
Glucocorticoids, released via the pituitary-adrenal-cortical axis, 
promote the development of diabetes, hyperlipidemia, and 
hypercholesteremia. Glucocorticoids enhance water diuresis, 
decrease circulating lymphocytes, increase platelet counts (which 
in turn enhances clotting tendencies), and increases gastric 
acidity and pepsin production. They also block growth hormone 
secretion, decrease calcium absorption, increase angiotensin 
production, suppress inflammatory responses, lower the electrical 
excitation threshold of the brain, and sensitize arterioles to the
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pressor effects of catecholamines (Eliot, 1982). It should be 
noted that, althqugh these systems do appear to affect CHD, the 
precise mechanisms through which they operate are still a matter 
of speculation (Krantz et al., 1982). This list of potentially 
adverse effects lends further credence to the importance of 
examining the mechanisms of reported reactivity in the Type A 
individual.
Stress
As mentioned, the two systems thought to be related to 
reactivity are the sympathetic-adrenal-medullary system and the 
pituitary-adrenal-cortical system. A mare detailed analysis of 
hew these systems are related to stress is necessary. As 
originally defined by Selye in 1936, the term stress in the 
present paper will refer to the "nonspecific (that is, ccnrnon) 
result of any demand on the body, be it mental arithmetic, somatic 
survival, and the accomplishment of our aims" (Selye, 1980, p. 
vii). During the course of his research, Selye modified the 
definition to more clearly distinguish between pleasant and 
unpleasant stress. He notes, however, that the distinction proves 
to be immaterial since it is the intensity of the demand for 
readjustment or adaptation that determines the response (Selye, 
1974). The use of the term nonspecific does not imply that all 
stress is identical. The stressor, that agent which produces 
stress, will necessarily have its specific effects. This 
specificity of the stressor does not contradict the term 
nonspecificity contained in the definition of stress. Instead,
29
the specificity of the stressor can be explained by the stressors 
side effects and the' internal and external predisposing factors 
that may modify the response.
The definition of stress proposed by Selye is based on his 
early research showing that there were three objective indicators 
that could be recognized no matter how stress was produced. These 
indicators were (a) the mobilization of the anterior 
pituitary-adrenal axis, (b) the reliable involution of the 
thymico-lymphatic system, (c) the appearance of peptic ulcers.
The appearance of these events, as well as other nonspecific 
indicators, defines the phenomenon of stress, irrespective of 
other changes that may occur following exposure to the stressor 
(Selye, 1980, p.vii). It would be misleading, though, to consider 
stress as a dichotanous yes-no type of phenomenon, stress, 
according to Selye, exists in varying degrees. That is, different 
demands of different intensities may not always result in 
identical or similar reactions. In each situation, the role of 
stress may be more or less important.
One source of confusion in the stress research involves the 
use of different formulations to conceptualize stress (McNamara, 
1982). A frequently used conceptualization is that of stress as 
an environmental event. This approach is most consistent with the 
study of the association between the accumulation of life events 
and the risk of physical illness. Holmes and Rahe (1968) 
stimulated research in this area by reporting strong positive 
, correlations between exposure to a large number of life changes
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and the risk of developing some kind of illness. It is beyond the 
scope of the present paper to review the tremendous proliferation 
of research that followed such findings. Suffice it to say, that 
such research was strongly criticized for yielding unreliable 
scores and including items reflecting illness (Holroyd, 1979). 
Babkin and Struening (1976), after an extensive review of the 
literature, concluded that life events have not been shown to be 
reliable predictors of the probability of future illness. life 
events research, while drawing attention to important sources of 
stress, tends to focus on linear associations between independent 
and dependent variables. Rabkin et al. (1976) call for future 
research to focus on the assessment of internal mechanians through 
which life events may have their impact.
Another well known approach to stress is that of stress as a 
response. This area is best exemplified by the work of Selye and 
his description of the General Adaptation syndrome (GAS, Selye, 
1936). The GAS (Selye, 1936) is a nonspecific response of the 
body to an intense or noxious demand. There are three distinct 
phases of the GAS— alarm, resistance, and exhaustion. Selye 
(1974) has proposed that prolonged or repeated elicitation of the 
GAS, or defects associated with this response, play an inportant 
role in a large number of stress-related diseases, including 
cardiovascular disease. The changes associated with these phases 
are mediated by the release of adrenocorticotropic hormone (ACTH) 
which stimulates the release of glucocorticoids, and the 
activation of the autonomic nervous system which liberates
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catecholamines from the sympathetic nervous system and by the 
adrenal medulla (Selye, 1974). Thus, "the body responds to 
increased physical or psychological demands by releasing 
ad renocorticotropin (ACTH) from the anterior pituitary, 
glucocorticoids from the adrenal cortex, epinephrine from the 
adrenal medulla, and norepinephrine from the sympathetic nerves” 
(Axelrod & Reisine, 1984, p. 452).
Although the work of Selye has provided an eloquent 
documentation of the pituitary-adrenal axis in reponse to a number 
of demands, it falls short of providing information about the role 
that psychological variables may play in influencing this 
response. Mason (1968, 1971) has argued that the stress response 
is mediated by psychological variables. A third approach to the 
study of stress is the transactional model. In this approach, 
stress is conceptualized as a transaction between a system and its 
environment. Stress is characterized by the cognitive processes 
that mediate the adaptive demands to the individual and the 
individuals' reponse to them. Lazarus (1966, 1971), using this 
approach, conceptualizes stress as an interaction between 
appraisal and coping processes.
Space limitations do not permit an extensive review of each 
of the factors involved in the stress response. The interested 
reader is referred to Axelrod et al. (1984) and Mason (1968). The 
focus of the following discussion will be on ACIH, because it is 
the hormone measured in the present study. When pertinent, 
however, interactions with other substances will be described.
32
Adrenocorticotropic Hormone
The release of ACTH is thought to be the main indicator of 
the onset of the "stress syndrome" or GAS (Makara, Palkovits, & 
Szentangothai, 1980). The influence of psychological factors on 
the pitiutary-adrenal-cortical system has been, perhaps, the most 
extensively studied of the endocrine systems, owing much to the 
work of Selye and to the availability of recently developed 
excellent biochemical methods of measurement (Mason, 1968). Human 
ACTH is a 39 amino acid, anterior pituitary polypeptide hormone 
(Krieger, 1979) controlled by complex regulatory mechanisms such 
as corticotropin releasing factor (CRF), vasopressin, 
catecholamines, and possibly other as yet unknown hormones 
(Axelrod et al., 1984). Several of these deserve brief 
elaboration, it is noteworthy that the release of ACIH in animals 
by catecholamines at sufficiently high levels (eg., that occurring 
during hypoglycemia and with myocardial infarction) can be blocked 
by propanolol, a beta-adrenoreceptor blocking drug. Further, 
isoproterenol-induced ACTH secretion has been reported to be 
blocked by calcium antagonists or a lack of extracellular calcium 
(Reisine, Heisler, & Hook, 1982).
Once secreted, ACIH stimulates synthesis of cortisol (in 
humans) which, in turn, serves to inhibit further secretion of 
ACTH (Axelrod et al., 1984). Because alternative methods of ACIH 
regulation have been reported, the measurement of changes in 
corticosterone (or cortisol) and adrenal weight, the most 
frequently used measures of stress, cannot be assumed to reflect
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pituitary ACTH in a quantitative manner (Krieger, 1979). in 
addition, the measurement of ACIH is thought to be at least one 
step closer than corticosterone to the site of neural initiation 
of the stress response (Vernikos-Danellis & Heybach, 1980).
The response of ACTH to an emotional stimulus is influenced 
by both the quality and strength of the stimulus (DeWied, 1980). 
Although the pituitary-adrenal system responds to a wide variety 
of psychological stimuli, those with an element of novelty, 
uncertainty, and unpredictability (Mason, 1968) or those 
resulting in fear, anxiety, and frustration (Selye, 1950), are 
among the most potent stressors for system activation, resulting 
in reportedly striking responses. The influence of stress upon 
ACTH has been said to be superimposed upon all other regulators of 
ACTH. Regardless of time of day or level of plasma cortisol, the 
normal individual responds to major stress with an increase in 
ACTH and a consequent increase in cortisol (Daughaday, 1981).
It is critical for researchers in the area to note that there 
exists a circadian periodicity for ACTH secretion (Krieger, 1978). 
This rhythmicity occurs in episodic, relatively synchronous peaks, 
with the majority of upward peaks occurring between 3:00 a.m. and 
9:00 a.m. so that the highest ACTH levels are found upon 
awakening, wakening is followed by a downward trend with episodic 
peaking (associated with mealtimes) and quiescent periods 
(Krieger, 1979). The normal range for early morning samples is 
21-139 picograms per milliliter (pg/fal) of blood plasma. Late 
evening samples range from 20 to 85 pg/fal (Buhmann-Wennhold &
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Nelson, 1979). ACTH periodicity is reported not to be affected by 
stress and is not dependent on corticosterone feedback (Krieger, 
1979). There has been sane controversy regarding whether ACIH 
rhymicity is normal or abnormal in psychiatric patients. Krieger 
(1978) notes that there appears to now be general agreement that 
such periodicity is normal, having perhaps more frequent episodic 
release.
Reactivity Studies
Studies show, in general, that Type As, as compared to Bs, 
respond to appropriate challenges, be they laboratory induced or 
naturalistic, with increases in blood pressure, heart rate, 
catecholamines, ACTH, cortisol,-and cholesterol (Krantz et al, 
1982). Hemodynamic and endocrine findings have led researchers to 
speculate about the roles of the sympathetic-adrenal-medullary 
and pituitary-adrenal-cortical stress response systems. The 
purpose of the present discussion is to relate the results of 
numerous studies that have accumulated in this area.
Hew and why the Type A behavior pattern confers coronary risk 
can be studied in several ways. First, do Type As behave in such 
a way as to frequently arouse the sympathetic nervous system? The 
greater bulk of the evidence here points to the importance of the 
roles of hostility, agressiveness, and competitiveness in Type A 
(Matthews, Glass, Rosenman, & Bortner, 1977; Carver & Glass, 1978; 
Williams, Haney, Lee, Kong, Blumenthal, & Whalen, 1980; Gentry 
Chesney, Gary, Hall, & Harburg, 1982; Barefoot, Dahlstrcm, & 
Williams, 1983; Shekelle, Gale, Ostfeld, & Paul, 1983). These
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investigations, which assess the role of hostility in Type A 
behavior, appear to follow two major directions. First, there are 
those studies that have demonstrated the existance of a predictive 
association between hostility in initially well subjects and 
subsequent development of CHD (Matthews et al., 1977; Barefoot et 
al., 1983; Shekelle et al., 1983). Similarly, Williams et al. 
(1980) and Dembroski, MacDougall, Williams, Haney, & Blumenthal 
(1985) reported significant positive associations between 
hostility and degree of coronary atherosclerosis that was 
independent of other factors.
A second way that the role of hostility has been studied is 
by subjecting Type As and Bs, primarily college students, to 
particularly difficult and frustrating tasks under conditions of 
harassment and non-harassment by a confederate. These studies 
(Glass, 1982; Carver & Glass, 1978) support hypotheses suggesting 
the critical role of hostility and aggressiveness in the Type a  
behavior pattern. Using a paradigm in which subjects were either 
exposed to a harassing or non-harassing confederate to wham they 
were to teach a complex perceptual motor task, Carver et al.
(1978) found that Type As, assessed by the student form of the 
JAS, delivered significantly higher levels of shock intensity to 
the harassing learner than did Bs. The work of Glass (1982) 
supported these findings. Using a competitive game situation in 
which subjects were randomly assigned to harass and no-harass 
conditions. Glass (1982) reported significantly greater levels of 
systolic blood pressure, heart rate, and catecholamines (i.e.,
36
epinephrine) among As, as compared to Bs, that were attributable 
to condition. Glass (1982) concluded that, although competition 
alone does not result in significant differences between As and 
Bs, the response to an element of hostile interaction results in 
enhanced responding among Type A subjects. These studies provide 
evidence, that the role of hostility, with subsequent sympathetic 
nervous system activation, may be one of the ways that CHD confers 
coronary in Type A persons.
Another question that needs to be addressed when attempting 
to explain hew Type A confers coronary risk, is whether there are 
seme as yet unidentified components that lead to increased 
coronary risk among Type A individuals. The association between 
psychosocial variables (other than Type A) and CHD has been 
examined (Dimsdale, Haekett, Block, 6 Hutter, 1978; Jenkins, 
Stanton, Klein, Savageau, & Harken, 1983; schweritz, McKelvaln, 
Laman, Patterson, Dutton, Yusim, Lester, Kraft, Rochelle, & 
Leachman, 1983; Freeman, Fleece, Folks, Cohen-Cole, & Waldo,
1984). Results thus far have been contradictory. Some authors 
have reported significant positive correlations between Type A and 
stressful life events, tension, depressive mood, and anger 
(Dimsdale et al., 1978) as well as fatigue, life dissatisfactions, 
and sleep disturbance (Jenkins et al., 1983). Schweritz et al. 
(1983) failed to find significant associations between 
psychosocial measures and extent of disease. Finally, one study 
(Freeman et al., 1984) reported unexpected results. These authors 
found that the incidence of arrhythmias following coronary artery
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bypass surgery was negatively correlated with measures of 
depression and anxiety. They reported that patients scoring lew 
on depression and on anxiety had a greater incidence of 
postoperative arrhythmmias. A3 can be seen, the results of these 
studies are far fron conclusive and further research is needed 
before definitive statements can be made regarding the role of 
other psychosocial factors in CHD.
Before reviewing studies that examine whether Type As, as 
compared to Type Bs, demonstrate reactivity to stressful 
situations, an additional issue must be addressed. This concerns 
the question about whether there is a predictive association 
between reactivity and CHD development, predictive associations 
have been reported showing that Type A Behavior is predictive of 
CHD development. There are also studies that show, in most cases, 
that Type A behavior is associated with degree of atherosclerosis 
(Blumenthal, Williams, Kong, Schanberg, & Thompson, 1978; Prank, 
Heller, KOmfeld, spom, & Weiss, 1978; Zyzanski, Jenkins, Ryan, 
Flessas, & Everist, 1976; Kahn, KOmfeld, Blood, Lynn, Heller, 6 
Frank, 1982). Supportive data is also provided by Friedman, 
Roserman, Straus, WUrm, & Kositchek (1968). These authors 
examined the coronary arteries of 51 of the original WCGS 
(Roserman et al., 1964) sample who died after the initiation of 
the study. Twenty-five of these subjects died of CHD arid the 
remaining 26 subjects died of causes unrelated to CHD. Twenty-two 
of the 25 CHD-related deaths (88 per cent) occurred in subjects 
assessed as Type A in the original WCGS. Further, these authors
t
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found that severe atherosclerosis was six times more likely in 
Type A subjects. However, data regarding whether or not 
reactivity itself can predict CHD is lacking. This author was 
only able to identify one such study. In a 23 year prospective 
study. Keys, Taylor, Blackburn, Brozek, Anderson, & Simonson
(1971) examined this issue. Subjects were 279 upper-class, 
employed men, aged 47-57, who were CHD-free at the initiation of 
study. These authors found that the most significant single 
predictor of CHD was diastolic blood pressure response to the cold 
pressor test. The hyperreactor group, compared to subjects not 
considered to be hyperreactors, was found to have 2.4 times the 
risk of CHD death or myocardial infarction. The next best 
predictor was a combination of cholesterol level and systolic 
blood pressure. Although the results of one study alone does have 
limited generalizability, the work of Keys et al. (1971) provides 
intriguing supportive data that reactivity is associated with 
disease development.
Returning to the issue at hand, that of how and why Type A 
confers coronary risk, one final group of data must be considered. 
The collection of studies that follow examined whether or not Type 
As, as compared to Type Bs, indeed shew cardiovascular and 
endocrine reactivity when exposed to a stressor. If one is to 
accept the tentative hypothesis that reactivity is related to 
coronary risk, and that this reactivity operates via synpathetic 
adrenal medullary and pituitary-adrenal-cortical axes, then such 
reactivity must be demonstrated in a variety of subjects exposed
39
to a variety of stressful tasks. The purpose of the following 
discussion is to critically review these studies.
t&unerous studies have been conducted which examine reactivity 
in cardiac patients manifesting the Type A behavior pattern.
Aside fran cardiac patients, several other populations have been 
used, including college students and healthy adults. Both 
laboratory-induced stressors (e.g., mental arithmetic, reaction 
time) and naturalistic settings/stressors (e.g., in the workplace, 
coronary artery bypass surgeries) have been used, although the use 
of the latter has been far more infrequent. Type A behavior has 
been assessed primarily with the SI and JAS in these studies. 
Finally, many different physiologic measures have been assessed.
The diversity of these studies does result in sane degree of 
confusion and controversy. The majority of the studies, however, 
demonstrate that Type A persons fail to differ from Type Bs under 
conditions of rest, but do tend to differ on sane physiologic 
variables when exposed to appropriate stressors. Studies using 
laboratory-induced stressors will be considered first.
Using a reaction-time task, Danbroski, MacDougall, & Shields 
(1977) found that Type A college students, assessed by the SI, did 
not differ at rest but responded to the BT task with significantly 
greater increases in heart rate (HR) and systolic blood pressure 
(SBP) when compared to Type B students. Greater HR variability 
was also observed in the Type A group. No differences were found 
for galvanic skin potential. Jennings (1984) also examined 
reactivity using a RT task in healthy students assessed for
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behavior type by both the SI and the JAS. Si-assessed Overall 
Type A was found to be significantly correlated with shorter 
vascular transmit times. Subjects scoring in the Type A direction 
of the Speed and Inpatience component of the SI were also found to 
exhibit greater task-related HR changes. Subjects did not differ 
during baselines between trials. No significant, associatios were 
revealed for the JAS. It should be noted that a predictive 
association between Type A and CHD has not been shown for the 
student form of the JAS (Jenkins et al., 1978). The results of 
these studies suggest that Type As do not differ frcm Type Bs 
during periods of rest, there is increased responsiveness to 
periods of stresss in Type A subjects. The work of VanBgeren
(1979) also supports the finding of increased HR to stress among 
Type As. Using a game situation, this author found that healthy 
college undergraduates, males and females, assessed by the student 
form of the JAS, responded with significantly greater HR as 
compared to Bs. No significant differences were found for blood 
volume pulse or respiration. Again regarding HR, an interesting 
finding was reported by Hart and Jamieson (1983). They found that 
both Type As and Bs, assessed via the JAS-student form, responded 
to a perceptual conflict task with increases in HR. However, they 
noted a significantly slower HR recovery after the stressor in 
Type As, perhaps suggesting that maladaptively prolonged 
cardiovascular arousal might be involved in the mechanisms 
underlying Type A and reactivity.
using cardiac patients and normal controls, Dembroski,
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MacDougal & Shields (1977) found that Si-assessed Type A subjects 
shewed greater increases in SBP and DBP, compared to controls on 
the si and a stressful history quiz, despite the use of 
beta-blockers in the cardiac patients. Corse, Manuck, Cantwell, 
Girdani, & Matthews (1982) also made use of a difficult series of 
cognitive tasks to study reactivity. Healthy adult controls and 
cardiac patients were assessed for behavior pattern using the JAS 
and the SI. CHD patients were reported to show greater DBP 
elevations, compared to controls, independent of behavior type. 
Si-determined Type As demonstrated greater increases in SBP and 
DBP during the experimental task. Subjects assesed by the JAS 
failed to show significant differences on the physiological 
measures. This latter finding appears perplexing at first glance 
because both the SI and the JAS are related to CHD risk. Several 
explanations are possible. Some researchers would suggest that 
the JAS fails to as sensitive as the SI in detecting physiological 
differences (Matthews, 1982; Gorse et al., 1985). It is also 
likely that the stressor was not of sufficient severity to induce 
greater reactivity in the JAS Type A subjects. Gorse et al.
(1982) suggested that for laboratory-induced stressors, the use of 
the SI may be more appropriate. Perhaps the use of extreme scores 
(ie., less than or greater than one standard deviation from the 
mean) for purposes of classification; may have resulted in 
different findings. Only future research will help to clarify 
these issues. The work of Williams & Lane (1982) may shed some 
light on this.. These authors used both the SI and the JAS to
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classify subjects (male college students) but only those 
classified by both techniques were used in the final sample. TWO 
different tasks— mental arithmetic and reaction time— were used. 
Results showed that, during the mental arithmetic task, Type As 
showed greater muscle vasodilation, and enhanced secretion of 
epinephrine, norepinephrine, and cortisol than did Type Bs. The 
reaction time task was found to be associated with higher levels 
of testosterone in Type A subjects. This well designed study 
suggests that physiological differences can be found when using 
the JAS. It also points to the importance of task selection.
Results contradictory to the reactivity hypothesis were
reported by Steptoe & Ross (1981). Using a series of cognitive
tasks and the JAS student form, they assessed normal volunteers,
and failed to find significant differences on cardiovascular
measures (i.e., interbeat interval, pulse transit time,
respiration, and galvanic skin response). In fact, Type Bs tended
to show greater reactivity on seme measures. This study also 
%
raises important questions about the appropriateness of the 
student form of the JAS. One should note also that the 
physiologic measures chosen have not been demonstrated to 
significantly differ in Type As and Bs in other studies.
A few studies using naturalistic settings or real-life 
stressors have been published. Endocrine reactivity (assessed via 
urinary epinephrine, norepinephrine, 17-ketoeteroids, 
17-hydraxycorticosteroids, and 5-hydroxyindole) was studied by 
Friedman, St. George, Byers, and Rosenman (1960). Si-assessed
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non-CHD male subjects collected urine during four consecutive 
workdays and upon awakening for four days. Results indicated 
that, at rest, catecholamine excretion did not differ. During the 
workday, only norepinephrine was found to be significantly related 
to Type A behavior. This study was probably among the first to 
demonstrate the lack of difference between As and Bs at rest, a 
finding which has been supported by later work. The lack of 
experimental control over the work situation and failure to 
measure workday stress are two inportant flaws in this study, and 
which are, perhaps, responsible for the lack of significance found 
on other variables.
The role of ACTH and cortisol was examined by Friedman, 
Roserman, and St. George (1969) and Friedman, Byers, and Rosenman 
(1972). Following the injection of 100 units of ACTH (reported to 
be twice the amount needed to effect a maximal cortisol 
discharge), three urine samples were obtained (one inmediately 
prior to injection, and one at 14 and 19 hours post-injection) so 
that analysis of 17-hydroxycorticosteroid (17-OHCS, a metabolite 
of cortisol and other adrenocortical glucocorticoid hormones) 
could be conducted. Subjects were 18 Type A and 20 Type B 
assessed by the early version of the SI. Results revealed no 
significant differences between basal levels of 17-OHCS. At 19 
hours, considerable differences were found. Type As were found to 
have excreted abnormally low levels of 17-OHCS as ccnpared to Bs. 
The hypo-respose of the Type As was perplexing. Friedman et al. 
(1969) postulated that this loss of "adrenal reserve" could be due
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to a previous long standing or excessive discharge of ACTH. The 
authors suggested that future research, comparing ACTH levels in 
Type A and B subjects was necessary before conclusions could be 
drawn. As a follow up study, Friedman et al. (1972) measured 
plasma ACTH, plasma cortisol, and plasma cholesterol 
concentrations during five intervals of the working day in 9 Type 
A and 10 Type B subjects. With in-group and between-group cortisol 
and ACTH varied considerably and resulted in failure to find 
significant differences. Despite this, however, the authors noted 
that average ACTH values of Type A subjects was greater than those 
of Type B subjects at each of the six sampling intervals.
Friedman et al. (1972) determined that there was a very low 
probability of observing these differences across all sampling 
intervals. They concluded from this that Type A subjects 
exhibited an increase in ACTH as compared to Type B subjects. 
Significance was found for the occurrence of greater peak values 
of ACTH in Type As. No significant differences were found for 
cortisol. As expected from their previous research, plasma 
cholesterol was significantly greater in Type As. Friedman et al.
(1972) concluded that this hypersecretion of ACTH suggested that 
there were alterations in the hypothalamo-pituitary-adrenal 
systems of these Type A subjects. Despite obviously problematic 
methodology (i.e., small sample size, lack of experimental 
control), significant differences were found for ACTH, attesting, 
perhaps, to the robustness of this measure. However, the 
weaknesses in the study suggest that the results should be
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interpreted with caution. Further research is necessary before 
definitive statements can be made. It is interesting to note that 
such research remains to be conducted.
A study conducted by Czeisler (1976) may help to shed sane 
light on the difficulties inherent in utilizing endocrine 
responses as measures of reactivity. Four coronary patients 
awaiting open heart surgery and five healthy volunteers 
(hospitalized for purposes of the study) served as subjects. 
Czeisler (1976) collected plasma cortisol samples every 20 minutes 
for the 24 hours prior to the experimental groups' scheduled 
surgery. Anxiety was rated by each subject on a five point scale 
during each of these intervals. Indistinguishable and normal 
patterns of cortisol secretion were found for both the control and 
experimental groups across all sampling intervals with only one 
exception. During preoperative preparation for surgery (i.e.,
i
shavingr antiseptic wash, and enema), experimental subjects had 
3.7 times higher cortisol concentrations than did controls ( £  < 
.001). in fact, cortisol in experimental subjects increased seven 
to 10 standard deviationsfran the control group mean obtained at 
the same time. No significant correlations were obtained between 
anxiety ratings and cortisol concentrations. These authors 
concluded that the experience of he pre-surgery situation alone 
did not result in hyperactivation of the pituitary-adrenal axis. 
Based on the results of cortisol secretion during preoperative 
preparation, Czeisler (1976) noted that, although cortisol is 
generated endogenously, it can be influenced by stress. Furthur,
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frequent blood sampling was recommended by these authors because 
failing to do so in this study would probably have resulted in 
overlooking the significant data. Although the study reported by 
Czeisler (1976) did not address Type A reactivity, it does 
illustrate the level of complexity involved in psychoendocrine 
research.
A few other naturalistic studies are available in the current 
literature (Kahn, KOmfeld, Frank, Heller, 6 Hoar, 1980; Krantz, 
Arabian, Davia, & Parker, 1982; KOmfeld, Kahn, Frank, Heller, 
Freeman, & Keller-Epstein, 1985). All three of these studies 
address hemodynamic reactivity in patients undergoing coronary 
artery bypass grafting (CABG). Kahn et al. (1980) examined 
intraoperative blood pressure in 59 cardiac patients, assessed for 
behavior type using the SI. Blood pressure values were obtained 
by subtracting admission blood pressure (BP) from maximum 
intraoperative BP values. Results revealed significant 
correlations between SBP rise and the SI components of Overall 
Type A, Aggressive Content, and Job Commitment. Diastolic blood 
pressure and Job Commitment were also found to be correlated.
These associations remained significant even when physical 
predictors of blood pressure rise were controlled. It is notable 
that significant hyperreactivity among Type A subjects was 
demonstrated despite patients being under general anesthesia.
These findings were supported by Krantz et al. (1982). Using both 
SI- and JAB-determined Type A and B cardiac patients undergoing 
CABG, Krantz et al. (1982) found that, after controlling for
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physical predictors of blood pressure riser Type A (SI assessed 
only) was significantly related to SBP increases during surgery. 
Correlations with the JAS scales were smaller and unreliable. In 
addition, these authors reported a larger incidence of surgical 
complications (i.e., arrhythmias) in si-assessed Type As. The JAS 
also failed to correlate with surgical complications, one should 
note, however, that the JAS analysis was conducted with an even 
smaller sample size (N * 21) than was originally used (N 3 27).
The results of Krantz et al. (1982) are consistent with previous 
research suggesting that conscious mediation is not necessary for 
Type A reactivity to occur. Disconfirming evidence was reported 
by Romfeld et al. (1985), although non-cardiac patients 
undergoing general elective surgery served as subjects. Kornfeld 
et al. (1985) failed to find significant associations between 
Si-assessed Type A and intraoperative hemodynamic changes. A 
trend was noted for Overall Type A score and DBP at baseline and 
intraoperatively.
The importance of controlling for medications when studying 
cardiac patients has been demonstrated by several studies.
Anxiety, at least in part, results from beta-adrenergic 
stimulation, and, therefore, drugs which reduce or block this 
response (i.e., beta-antagonistic drugs such as propanolol) would 
be expected to influence the hemodynamic and endocrine response to 
a stressful situation, particularly in subjects with somatic 
manifestations of anxiety. Beta-blockers are said to exert their 
greatest influence when sympathetic nervous system activity is
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intense (Durel et al., 1985) suggesting the need for control when 
examining the stress response in cardiac patients. The early work 
of Granvi1le-Grossman and Turner (1966) provided the first 
evidence that the use of propanolol was associated with a decrease 
in investigator-rated and personal symptom ratings of anxiety. 
Since this time, a number of studies have been conducted with 
beta-blocker treated cardiac patients under stress. A variety of 
different stressors have been used and results have not been 
conclusive. Seme cannon results can be found across studies.
Using normals and hypertensives exposed to a reaction time task, 
Heidbreder, Rockel, & Heidland (1978) found no effects of 
beta-blockade for HR. Different results were obtained by Bonelli, 
Hortnagl, Maganetschnigg, Lochs, & Kaik (1979). These authors 
found a significant association between HR decrease and 
beta-blockade in normal volunteers' response to calculation 
stress. No effects were found for BP, E, or NE, although a very 
small sample size (N ■ 6) was used. Neftel, Adler, Kappeli,
Rossi, Dolder, Kaiser, Bruggesser, & Vorkauf (1982) supported the 
findings from previous research that HR and beta-blockade were 
significantly related. However, again, no effect was found for 
catecholamines. Bonelli (1978) also found significantly reduced 
HR, as well as cardiac output, SBP and DBP reduced by 
beta-blockade. Bonelli (1978) also failed to find that 
beta-blockade significantly altered catecholamine response. One 
study that specifically addressed the association between Type A 
and beta-blockade was conducted by Krantz, Durel, Davia, Schaffer,
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Arabian, Dembroski, 6 Macdcogall (1982). Using a stressful 
interview and a history quiz, these authors found that propanolol 
treated patients showed less Si-assessed Type A characteristics, 
lesser HR, and lesser rate-pressure products, a correlate of 
myocardial oxygen supply. These effects were not found in 
patients being treated with nitrates, central nervous system 
drugs, or diuretics. No significant differences were found for 
BP. The JAS-assessed Type A behavior was not related to 
medication.
Although definite conclusions cannot be drawn fran these 
studies, the evidence, in general, appears to support the notion 
that beta-blockade is useful in reducing seme physiologic 
manifestations of anxiety (Durel et al., 1985). The most 
consistent effects appear to be on HR. There is still 
considerable controversy regarding BP and catecholamine response 
to stress and beta-blockade. A particular problem area appears to 
be the use of small sample sizes.
Several investigators have also examined the effects of 
calcium antagonists on physiologic reactivity (Corea, Miele, 
Bentivoglio, Boschetti, Agabiti-Rodei, & Muisesan, 1979; Taylor, 
Silke, Ahuja, & Lkoli, 1982; Heidbreder, Schafferhans, Kirsten, & 
Heidland, 1983; Pederson & Mikkelsen, 1978). Pederson and 
Mikkelsen (1978) reported significant decreases in HR and vascular 
resistance, and a significant increase in forearm blood flow, with 
acute administration of nifedipine in hypertensive patients.
Corea et al. (1979) found a sustained decrease in BP (without HR
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increase) in hypertensives. In normals, a significant increase in 
HR was found without any change in HP. In response to three 
different pressor stimuli, Taylor et al. (1982) documented a 
significant dose-related reduction in BP in six male 
hypertensives. Heidbreder et al. (1983) examined the physiologic 
response (via BP, HR, and catecholamines) to a mental stressor in 
normal persons taking either a calcium antagonist, nifedipine, or 
a diuretic, hydrochlorothiazide. The purpose of this study was to 
determine whether drugs with a hypotensive effect, but without 
sympatholytic properties, would result in the suppression of an 
emotional response to a stressor. The results of the study did 
not support this hypothesis and the authors concluded that neither 
drug inhibited emotional stress in normotensive subjects. Hie 
results of these studies are also controversial as are those 
investigating the effect of beta-blockade. Future reactivity 
research, controlling for the effect of medications, may shed seme 
light on this confusion..
As can be seen frcm the foregoing review, findings within the 
area of Type and reactivity are not unequivocal. Although the 
greater majority of studies do shew that Type As appear to be more 
reactive to stress than Type Bs, it is still a matter of 
speculation whether reactivity confers risk, it may also be 
obvious to the reader that several variables appear to influence 
reactivity. To summarize, characteristics of baseline, task 
(stressor), subject, and response measure assume critical 
importance. According to Houston and Ewart (1984), tasks that
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provide a challenge, ccnpetition, or threat, have most often 
resulted in reactivity in Type A subjects. The use of such a wide 
variety of these parameters has resulted in same degree of 
confusion in the Type A literature. Future research aimed at 
isolating the important dimensions of these parameters is needed. 
Surrmary
The Type a  Behavior pattern, originally described by 
cardiologists Friedman & Rosenman (1959), is best characterized as 
a set of overt behaviors which can be elicited fran a susceptible 
individual given an appropriately challenging environment 
(Matthews, 1982). The central elements of the behavior pattern 
appear to be a sense of time urgency, easily aroused hostility, 
and competitive achievement striving. Epidemiological studies, 
notably those of Rosenman et al. (1964, 1975) and Haynes et al. 
(1978, 1980), have shown that the Type A Behavior Pattern is 
significantly associated with an increased incidence of coronary 
heart disease, even when traditional risk factors are controlled. 
In 1981, the Review Panel on Coronary-Prone Behavior and Coronary 
Heart Disease concluded that Type A behavior is an independent 
risk factor for clinically apparent coronary heart disease and 
that the magnitude of risk associated with this behavior pattern 
is as great as those imposed by traditional risk factors such as 
elevated systolic blood pressure, smoking, and serum cholesterol.
As evidence began to accumulate in the area of Type A 
research, same authors began to speculate that psychophysiologic 
responsiveness (i.e., reactivity) could be a marker in the
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development of cardiovascular disease (see reveiw by Krantz et 
al., 1984). it was hypothesized that pathologic neuroendocrine 
and cardiovascular responses could link psychosocial stress to 
cardiovascular disease. A great deal of attention was then 
focused on the roles of the sympathetic adrenal-medullary system 
and the pituitary adreno-cortical system.
A variety of stressors have been used in the study of 
reactivity, including both laboratory (e.g., mental arithmetic, 
reaction time, cold pressor) and naturalistic (e.g., cardiac 
catheterizations, treadmill tests, and coronary bypass surgeries) 
settings. There is a substantial body of data to show that Type 
As and Bs fail to differ under conditions of rest. Under stress, 
however. Type As almost consistently shew differences, as compared 
to Type Bs, on at least one of the neuroendocrine and/or 
cardiovascular measures under study, under conditions of stress. 
Type As, as compared to Type Bs, tend to show larger episodic 
increases in blood pressure, heart rate, catecholamines, ACTH, and 
cortisol. It is noteworthy that larger differences are often 
found when real-life stressors are used, attesting to the 
importance of task selection in this area of study.
Several shortcomings within the area of reactivity were noted 
in the foregoing review. First, although a great deal of research 
has assessed the catecholamine (e.g., norepinephrine, epinephrine) 
response to stress, little attention has been paid to the release 
of adrenocorticotropic hormone (ACTH) in response to stress. Only 
two studies, published in the late 1960s and early 1970s, were
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found in the literature. In comparison to studies that examined 
catecholamines and cortisol, these two ACTH studies reflect a 
deficit in the area. Further, recall that pituitary ACTH cannot 
be assumed from measures of cortisol concentration (Krieger,
1979). It would appear then that little is known about ACTH 
reactivity in Type A subjects. This represents a major gap in the 
literature, particularly in light of the importance of ACTH in the 
stress response. ACTH is a well documented indicator of stress 
(Axelrod, 1984) and the present study utilizes this measure as a 
physiological dependent variable, second, the use of laboratory 
stressors dominates the area and several researchers have 
suggested the need for more naturalistic studies (Krantz et al., 
1984). Further, the JAS has been infrequently used, or has been 
used with small samples, such that less is known about 
JAS-assessed Type A responses to a challenge or stressor. The 
objectivity of the JAS, as well as sane practical considerations, 
suggests that its use in Type A assessment will continue so that 
the importance of establishing its parameters is necessary. The 
present study compares the responses of JAS-assessed Type As and 
Bs to a real-life cardiac catheterization. Finally, until 
recently there has not been adequate attention placed on the 
importance of medications and how they might alter the stress 
response. Existing research has thus far been inconclusive. 
Because of a number of practical problems, the most important of 
which was sample sizes, it was not possible in the present study 
to form different drugs groups. The next best approach, that of
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comparing patients on target medications (i.e., beta-blockers, 
calcium-channel blockers or both of these) to those that were not 
on target medications, was used. In addition to the advantage of 
controlling these variables, the present study also attempted to 
investigate the effects of these medications on the response to 
stress.
Purpose of the Present Study
The purpose of the present study was to investigate hew 
cardiac patients, identified as manifesting Type A or Type B 
Behavior Patterns, would respond to the stress of cardiac 
catheterization. The primary reseach question being asked was 
whether the Type a  cardiac patients would show an increased 
physiological and psychological reactivity (i.e., exaggerated 
response) to the stressor. Limited ACTH research thus far would 
suggest that Type A individuals are indeed more reactive to stress 
than their counterparts, the Type B individual. However, 
published findings (Friedman et al., 1969, 1972) have been few and 
not without controversy. One of the important aims of the present 
study, therefore, was to aid in the clarification of this 
phenomenon, particularly with respect to the role of ACTH in the 
response to stress. Another important research question addressed 
in the present study was that of how medications might influence 
or alter the response to a stressor. Patients in the study were 
divided into two medication groups. Patients taking beta 
adrenergic blockers, calcium entry blockers, or both of these 
drugs formed the drug condition of the independent variable of
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Drug Group. Patients not taking any of these medications formed 
the no drug condition of Drug Group.
Based on the findings fran previous research, several 
hypotheses were formulated.
1. All subjects are expected to show some degree of hormonal 
(i.e., ACTH) and cardiovascular (i.e., HR and BP) responsivity to 
the stress of cardiac catheterization. Although individual 
differences will exist, there is substantial data to suggest that 
exposure to stress results in the mobilization of the 
synpathetic-adrenal-medullary system and the
pituitary-adrenal-cortical system (Axelrod et a., 1984). This is 
said to be particularly true when a stressor has an element of 
uncertainty or unpredictability (Mason, 1968) or when it results 
in fear and anxiety (Selye, 1950). The cardiac catheterization 
can be said to possess many of these elements, and therefore, 
aside fran individual differences that might exist, a general 
response to stress can be expected across all subjects.
2. ttamerous studies previously reviewed (e.g., Krantz et 
al., 1982; Eliot, 1982) suggest that Type A individuals, in 
comparison to Type Bs, tend to shew exaggerated responsivity 
(i.e., reactivity) to stressful situations. Although sane 
discamfinning evidence has been reported, Type A subjects have 
been shown to respond to stress with greater elevations in HR and 
BP (Dembroski et al., 1977; VanEgeren, 1979; Hart et al., 1983; 
Corse et al., 1982; and Kahn et al., 1980) and ACTH (Friedman et 
al., 1969,1972). Therefore, Type A subjects in the present study
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are expected to shew greater hormonal and cardiovascular 
reactivity than Type B subjects.
3. Drug Group (i.e., drug versus no do drug) is also 
expected to influence reactivity to stress. Although again 
research in this area has not.been without controversy, the 
findings reported by Bonelli (1978, 1979) and Krantz et al. (1982) 
suggest that beta-blockade (i.e., treatment with beta-adrenergic 
blocking drugs) is useful in reducing physiologic manifestations 
of anxiety. Durel et al. (1985) note that the most consistent
finding is that of HR reduction. With respect to calcium-channel
*
blockers, evidence is even more sparse and equally conflictual. 
Several researchers (Pederson et al., 1978; Corea et'al., 1982; 
Taylor et al., 1982) have reported that reductions in HR and BP 
occur in patients treated with calc ium-channel blockers.
Conversely, Heidbreder et al. (1983) reported that treatment with 
these drugs does not suppress the emotional response to a 
stressor. No data appear to be available with regard to the 
combined treatment of both beta-blockers and calc ium-channel 
blockers. However, clinical observation (Usher, 1985) suggests 
that the effect of the beta-blocker will "override" the effect of 
the calc ium-channel blocker. Therefore, the predicted primary 
effect of the Drug Group is that of beta-blockade and 
consequential stress reduction. Subjects in the No Drug condition 
are expected to show the greatest response to the stressor. The 
hypothesis related to the influence of drug group upon Behaior 
Type is illustrated as follows: Type A (neither drug) > Type A
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(drug) > Type B (neither drug) > Type B (drug).
4. Regarding psychological measures (i.e., anxiety and mood 
scales), similar events are hypothesized. Following the logic 
proposed in the preceding hypotheses, all subjects are expected to 
show seme degree of psychologic responsivity. Type A subjects, as 
compared to Type B subjects, are expected to demonstrate 
exaggerated responsiveness and medications are expected to 
influence this response. That is, patients in the Drug Group are 
expected to report less anxiety and mood disturbance because of 
the perception of less somatic manifestation of anxiety produced 
by these drugs. Further, subjects showing elevated trait anxiety 
scores are predicted to demonstrate greater psychologiceil and 
physiological responsiveness.
i
CHAPTER TOD 
Method
Subjects
Sixty-three patients of the Medical University Hospital in 
Charleston, SC, referred for cardiac catheterization frcm 
November-June, 1986, served as subjects in the present study. 
Partial data was also collected on an additional 21 subjects that 
could not be included in data analysis. Eleven of these 21 
subjects were not available for post-catheterization follow-up 
because of other scheduled diagnostic tests or because of the 
necessity for emergency surgery. Approximately six subjects were 
lost because of experimenter error. An additional two subjects 
were excluded because of conditions unknown to the experimenter at 
the time of data collection (i.e., pacemaker and dialysis 
patient). One subject was excluded because of an invalid JAS 
(i.e., greater than six items unanswered). Another subject did 
not undergo scheduled catheterization. Criteria for inclusion in 
the study were: (a) English-speaking white males between the
ages of 25 and 70 referred for diagnostic workup for symptoms of 
coronary heart disease (eg., angina, myocardial infarction); (b) 
consent of primary physician; and (c) willingness to participate 
in the study. Patients were excluded from the study if they had 
(a) previous coronary surgery; (b) diseases known to affect ACTH 
production (e.g., Cushing's disease); (c) cardiovascular 
physiology was controlled by artificial means (e.g., pacemaker), 
or (d) if they were taking long term psychotropic medications.
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Independent variables
The Type A Behavior Pattern was assessed using the Jenkins 
Activity Survey-Form C (JAS, Jenkins et al., 1979). The JAS was 
computer scored and standard and percentile scores were obtained 
to yield an Overall Type A score and three factor scores—  Speed 
and Inpatience, Job Involvement, and Hard-Driving and Competitive. 
Subjects were designated as Type A or Type B according to a median 
split using the Overall Type A standard score.. That is, subjects 
scoring in the positive direction (i.e., greater than the mean of
0.00) were identified as Type A subjects. Type B subjects were 
those with Overall Type A scores in the negative direction (i.e., 
less than the mean of 0.00).
Subjects were also be grouped according to what type of 
medication they were taking for their coronary synptans. within 
each of the two behavior groups (A or B), two medication groups 
were formed: (a) patients taking beta-adrenergic blocking agents
(e.g., propanolol), calcium entry blocking agents (e.g., 
nifidipine, and patients taking both of these drugs; and (b) 
patients taking neither of these two drugs.
Dependent Variables: Physiological
All dependent measures were obtained on each of two occasions 
for each subject— approximately one hour prior to catheterization 
(stress condition) and the morning after the catheterization 
(non-stress condition), 24 hours after pre-catheterization 
measures were obtained.
The major dependent variable assessed in the study was level
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of plasma adrenocorticotropic hormone (ACTH). Two fasting blood 
samples were obtained as described above. ACTH samples were 
analyzed using Nichols Institute Diagnostics commercial ACTH 
radioimmunoassay (RIA) kits. For the present experiment/ 10.0 
milliliters of venous blood was collected in siliconized glass 
tubes, with EDTA added as a anticoagulant/ on each of two 
occasions (i.e., pre- and post-catheterization). To prevent 
enzyme degradation, blood samples were kept on ice until 
centrifuged and frozen. Plasma was separated after samples had 
been centrifuged at 2200 x gravity, 4 degrees centigrade for 15 
minutes and at 7500 x gravity, 4 degrees centigrade, for 10 
minutes. Plasma samples were stored at -80 degrees centigrade 
until assay.
The radioimmunoassay procedure is based upon the principles 
of competitive binding established by Berson et al. (1968). The 
basic principle involves the measurement of unlabeled ACTH (i.e., 
unknown sample) by its ability to compete with radiolabeled ACTH 
for specific antibody binding sites. Known concentrations of ACTH 
(i.e., standard samples provided in the kit) are used to establish 
a dose-response curve. Patient samples are then evaluated by 
comparison with this curve. As concentrations of unlabeled ACTH 
increase, the amount of radiolabeled ACIH bound to antibody 
decreases proportionately. In a sample of 278 healthy adults, 
Nichols Institute (kit manufacturer) reported the normal range of 
ACTH to be less than 130 pg/ml. Normal values are also routinely 
established by each laboratory as one of the many accuracy checks
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involved in the RIA. Using 13 healthy adults, the present 
investigator found that all values were belcw 130 pg/tnl ( M = 42 
pg/inl, SD » 37.00).
The instructions for the radioimmunoassay were followed 
exactly with the exception of an addition of two other standard 
samples. All samples were assayed in duplicate and pre and post 
samples for each patient were analyzed in the same assay. All 
samples were counted in a Model 1282 Ganmacounter (Wallace 
Instruments, Inc.). Samples with counts per minute exceeding 
that of the maximum binding tube were incalculable and were 
excluded frcm the analysis ( £  = 12). Therefore, only 48 ACTH 
samples on each Day 1 and Day 2 are included in ACTH analyses. It 
is not known what produced the enhanced binding in these subjects.
Reliability of plasma ACTH radioimmunoassays has been 
reported by Berson et al. (1968). When duplicate samples are 
assayed during the same procedure, levels of agreement have been 
reported to be excellent. Somewhat less agreement has been 
observed when duplicate samples are assayed in two different 
procedures. In the present study, duplicate samples were analyzed 
in the same assay.
In order to assess group differences in level of arousal, 
other physiologic measures reflecting anticipatory anxiety were 
obtained. These were blood pressure (as measured by 
sphygmcmancmetry) and heart rate (as measured using radial pulse) 
obtained once under both conditions of stress and non-stress as 
described above. For each subject, each of these measurements was
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taken using the same a m  and with the patient in the same physical 
position (i.e., lying in bed).
Dependent Variablest Psychological
TWo psychological measures were used to assess subjects level 
of perceived stress. The State-Trait Anxiety Inventory-Form X 
(STAI, Spielberger, Gorsuch, & Levine, 1970) and the Profile of 
Mood States (PCMS, McNair, Lorr, & Droppleman, 1971) were 
administered to all subjects under both conditions of stress and 
non-stress. The State portion of the STAI and the POMS were used 
to assess current level of arousal. The Trait portion of the STAI 
was used in order to investigate associations between 
self-reported trait anxiety and measures of reactivity.
The STAI is composed of two separate self-report scales for 
measuring state anxiety (A-State) and trait anxiety (A-Trait).
The A-State portion of the inventory contains 20 statements to 
which the subject is instructed to respond according to how he or 
she feels at that particular moment. The A-Trait portion is 
similar, however, the subject is instructed to respond according 
to how he or she generally feels. A four-point scale (not at 
all, somewhat, moderately so, and very much so) is used on both 
inventories. Test-retest reliability for the A-Trait has been 
found to range from .73 to .86. A-State test-retest reliability 
is much lower (i.e., .16 to .54) as would be expected since moment 
to mcment anxiety levels are likely to fluctuate. Internal 
consistency has also been demonstrated with reliability 
coefficients ranging from .83 to .92. Construct and concurrent
63
validity have also been demonstrated (see Spielberger et al., 
1970).
The FCMS is a 65-item adjective rating scale in which the 
subject is instructed to use a five-point scale to indicate how he 
or she has been feeling during the past (time set). For 
purposes of the present study, a time set of Right Now was used. 
The five-point rating scale is composed of: not at all, a little, 
moderately, quite a bit, and extremely. Six factor scores are 
derived: (a) Tension-Anxiety, (b) Depression-Dejection, (c)
Anger-Hostility, (d) Vigor-Astivity, (e) Fatigue-Inertia, and
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(f) Confusion-Bewilderment. A Total Mood Disturbance (TOD) score 
was computed by summing all scores except Vigor-Activity. This 
latter factor score was subtracted from the sum of the other 
factor scores resulting in the TOD score. Only the TOD score was 
used in the present analyses. For a more thorough description of 
these factor scores, the reader is referred to McNair et al.
(1971). Both the rest-retest reliability (ranging frcm .61 to 
.69) and internal consistency (.90 and above) estimates have been 
highly satisfactory. Evidence for the predictive and construct 
validity of this self-report instrument has been demonstrated in 
brief psychotherapy studies and controlled outpatient drug trials. 
Procedure
Patients scheduled for cardiac catheterization are usually 
hospitalized for 36-48 hours. Prior to hospital admission, all 
patients were provided with an information booklet (Purcell, 1982) 
which described the catheterizaton procedure in simple terms.
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Following admission, potential subjects were recruited by the 
principal investigator. Patients were told that the present study 
was designed to investigate how different individuals responded to 
the stress of cardiac catheterization. After signing an approved 
informed consent agreement (see Appendix A), subjects completed a 
Personal Information Form (see Appendix B) which requested 
demographic information (age, education, occupation) and 
information regarding traditional risk factors (e.g., family 
history of cardiovascular disease, smoking history, etc.). The JAS 
and the Trait portion of the STAI were also completed at this 
time. Subjects were also seen on this day by the attending 
cardiologist or the Cardiology Fellow in order to answer any 
remaining questions that the subject (patient) may have had 
regarding the cardiac catheterization.
' On the morning of the procedure, prior to sedation with an 
oral dose of secobarbitol lOOmg, vital signs (BP and HR) and blood 
samples were obtained by a registered nurse on the unit. The STAI 
and the PGMS were completed by the subjects at this time. These 
measures were obtained, as closely as possible, at approximately 
one hour prior to scheduled time of catheterization. Delays 
and/or changes in expected time of catheterization did occur due 
to procedures followed by the catheterizaton team. However, once 
measures were collected, these subjects were included in the data 
analysis unless they became unavailable for post-catheterization 
data collection procedures (e.g., next day emergency surgery).
No attempt was made to assess fear of the blood-drawing procedure.
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However, a number of patients refused to participate in the 
present study stating this fear as the primary reason for 
nonccmpliance with the study.
All catheterizations were performed by the Fellow in 
Cardiology under the supervision of the attending cardiologist. 
Standard clinical cardiac catheterizations were done. 
Catheterizations for subjects in the present study were limited to 
those scheduled between the hours of 7:00 a.m. and 12:00 p.m. 
Catheterizations were conducted Monday through Friday. All 
patients were again seen by their physician on the evening of the 
catheterization for a report of preliminary findings and 
recommendations. It was impossible to alter this routine without 
disrupting the standard procedure followed by the catheterization 
team. Therefore, this information was taken into account in the 
statistical analyses.
On the day after the catheterization, 24 hours after 
dependent measures were obtained the previous day, fasting blood 
samples and vital signs were obtained and the STAI and the FCMS 
were again completed.
Each subject's medical chart was also reviewed in order to 
obtain information on traditional cardiovascular risk factors, 
medications, and catheterization results and recommendations. 
Catheterization recommendations were recorded as (a) surgery 
necessary, (b) medication only, and (c) other. The category of 
other was used to indicate a more general recaronendation of 
further procedures (i.e., coronary angioplasty or a trial of
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medication followed by surgery if unsucessful).
Upon completion of data collection, subjects were debriefed 
and thanked for their participation.
Experimental Design and statistical Analysis
A 2 x 2 x 2 (Behavior Pattern x Drug Group x Day) mixed 
effects design was employed, two levels of behavior pattern (Type 
A or Type B) and two levels of drug group (drug and no drug) were 
used. Day served as the repeated factor. There were two levels 
of day: pre-catheterization (Day 1) and post-catheterization (Day 
2). Day 2 was conceptualized as the best available assessment of 
baseline functioning. Initially, the study was designed to 
investigate four drug groups: beta-blockers, calcium channel 
blockers, a combination of both of these, and a group of subjects 
who did not take either of these two medications. Due to small 
sample sizes, in general, and the loss of 12 ACTH samples, in 
particular, it was deemed that the use of four drug groups would 
be impractical. Therefore., drug groups were collapsed to form 
two levels of the independent variable of drug group. The drug 
condition (level) was composed of patients taking beta-blockers, 
calcium-channel blockers, or a combination of these. The no drug 
condition was comprised of patients taking neither of these two 
drugs.
CHAPTER THREE 
Results
A total of 63 subjects were available for analysis. After 
means and standard deviations were calculated, an analysis of 
outliers was conducted. A total of 15 subjects were found to fall 
at least two standard deviations from the mean on at least one 
dependent variable. Removal of 15 subjects was deemed to be 
impractical as it would have greatly reduced sample size to 
unacceptable levels. Therefore# only those subjects with scores 
of at least three standard deviations from a mean of a particular 
dependent variable mean were excluded. Outliers on any one 
dependent variable were excluded from all analyses. After three 
subjects were excluded# the final sanple was 60. Statistical 
analyses were conducted on the full sanple ( N - 60) and an a 
subsample of this population referred to as the extreme sanple ( N 
“ 30). The extreme sanple was canpoeed of subjects from the full 
sanple who scored in the upper (i.e.# extreme Type A) and lower 
(i.e.# extreme Type B) quartiles on the Overall Type A scale of 
the JAS.
Full Sanple
Subjects ranged in age from 37 to 69 years ( M - 53.45# SD - 
9.68# N « 60). Additional demographic data is presented in Table
1. Twenty-eight Type As and 32 Type Bs ware identified. Means 
and standard deviations for the four JAS scales are presented in 
Table 2.
Chi-square analysis revealed no significant differences
Table 1
Demographic Characteristics of Sample (N- 60) 
Variable Per Cent
Education
< 12 years 23.0
high school 25.0
some college 20.0
college degree 32.0
Employment
full-time 56.0
part-time 3.0
unemployed 2.0
retired 38.0
History of Myocardial Infarct 48.0
Family History of CHD 58.0
Hypertension 35.0
Diabetes 15.0
Hyperllpldemia 10.0
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Table 2
Mean Standard Scores of Jenkins Activity Survey (JAS) Factors for 
Type A (n»28) and Type B (n=32) Subjects
JAS Type A Type B
Overall Type A M = 9.30 M a -8.37
SD a 6.25 SD = 3.96
Speed & Impatience M = 6.16 M = 6.82
SD = 6.57 SD a 8.85
Job Involvement M = -1.24 M a -9.85
SD a 11.25 SD a 8.11
Hard-Driving & Competitive M a 4.50 M a -0.91
SD a 10.06 SD a 10.80
Note. The JAS factors are scored such that the normative means 
are 0.00 and the standard deviations are 10.00.
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between behavior type or drug group for age, education, 
occupational status, history of myocardial infarction, family 
history of CHD, diabetes, hyperlipidemia, or cigarette smoking. 
Presence or absence of hypertension was found to be significant 
for drug group, X (3, N » 60) * 9.06, £ < .03.
A one-way ANOVA was also conducted for catheterization 
recommendations (i.e., surgery, medication, other) to examine 
whether knowledge of recommendations influenced the dependent 
variables obtained on day 2. No significant differences were 
found.
A 2 x 2 x 2 (Behavior Type x Drug Group x Day) analysis of 
variance (ANOVA) with repeated measures on day was performed for 
all dependent variables using both the full sanple ( N >60) and 
the extreme sanple ( N - 30). Dependent variables were 
adrenocorticotropic hormone (ACTH), systolic blood pressure (SBP), 
diastolic blood pressure (EBP), state anxiety, and total mood 
disturbance (TMD). statistical summary tables for the full sanple 
are presented in Appendix C. Statistical summary tables for the 
extreme sanple are presented in Appendix D.
Using the full sanple, a significant main effect for Day was 
revealed for ACTH, F (1, 44) * 6.38, £  < .01. Mean ACTH 
concentrations for day 1 (pre-catheterization day) and day 2 
(post-catheterization day) were 43.17 pg/faL (picograms per 
milliter of plasma) and 34.57 pg/ml, respectively. A significant 
main effect for drug group was also revealed for ACTH, F (1, 44) ■ 
4.42, £  < .04. Subjects in the drug condition exhibited a mean
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ACTH level of 35.33 as compared to a mean of 47.48 for subjects in 
the no drug condition. A significant Type x Drug interaction was 
found for ACTH. F (1, 44) - 9.63. £  < .003. The interaction is 
illustrated graphically-in Figure 1. Relevant means and standard 
deviations are presented in Table 3. Inspection of Figure 1 
reveals that Type B subjects did not differ regardless of drug 
condition, in contrast. Type A subjects exhibited substantially 
larger ACTH concentrations in the no drug condition as compared to 
the drug condition. Further. Type A subjects on no drugs 
exhibited much larger responses to the stressor than did Type B 
subjects on no drugs.
In terms of the full sanple. a main effect for Day was found 
for SBP. F (1. 56) ■ 4.51. £  < .04. Systolic blood pressure on 
day 1 was 122.78 itmHg (millimeters of mercury) as compared to 
118.68 mmHg for subjects on day 2. A Type x Day interaction was 
also revealed for SBP. F (1, 56) = 6.39. £  < .01. The interaction 
is graphically illustrated in Figure 2. Means and standard 
deviations for this interaction are presented in Table 4. 
Inspection of Figure 2 reveals that SBP for Type As and Type Bs 
did not differ on day 1. In contrast, Type As demonstrated 
substantially lower levels of SBP, as compared to Type Bs, on day 
2.
No significant main effects or interactions were revealed for 
C6P. HR, or TMD. The only effect revealed for state anxiety was a 
main effect for day, F (1, 56) ■ 3.97, £  < .05. This main effect 
for day reflected a significant difference between 36.02 for day 1
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Table 3
ACTH Means and Standard Deviations for Type x Drug x Day
(N - 48)
n ZEE® Drug
6 A no drug
6 A no drug
16 A drug
16 A drug
8 B no drug
8 B no drug
18 B drug
18 B drug
M SD
1 77.87 34.40
2 54.14 31.01
1 34.33 21.41
2 25.18 13.50
1 34.38 12.08
2 32.78 17.68
1 43.37 33.10
2 37.20 27.34
r-
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Table 4
SBP Means and Standard Deviations for Type x Drug x Day 
( N - 60)
ja Type Drug
8 A no drug
8 A no drug
20 A drug
20 A drug
10 B no drug
10 B no drug
22 B drug
22 B drug
Day M SD
1 128.62 32.71
2 112.25 10.71
1 121.25 16.94
2 115.50 13.84
1 121.20 16.73
2 124.80 21.56
1 122.77 15.50
2 121.14 12.19
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and 33.93 for day 2. Means and standard deviations for State 
Anxiety, EBP, HR, and TWD are presented in tables 5/ 6, 7, and 8, 
respectively.
Extreme Sample
A 2 x 2 (Behavior Type x Day) ANOVA with repeated measures on 
day was conducted for the extreme sample ( N ■ 30). No main 
effects for type or Type x Day interactions were revealed for any 
of the dependent variables. Two significant main effects for day 
were found for HR, F (1, 28) =■ 4.30, £  < .05, and for state
anxiety, F (1, 28) * 4.07, £  < .05. The means for HR for this
extreme sample were 68.40 and 71.07 for day 1 and day 2,
respectively. For state anxiety, the main effect for day
represents a significant difference of 36.23 for day 1 and 33.03 
for day 2.
Correlational Data
Pearson correlations were obtained among all dependent 
variables. The correlation matrix is presented in Table 9. For 
purposes of clarity of presentation, dependent measures will be 
classified as (a) biochemical, including ACTH; (b) 
cardiovascular, including SBP, DBP, and HR; or (c) psychological 
or self-report, including State Anxiety and TMD. Inspection of 
the matrix reveals that the agreement between each dependent 
variable on day 1 and day 2 was highly significant. For example, 
ACTH on Day 1 was highly related to ACTH on Day 2 ( £  < .001).
With only one modest exception, no significant associations were 
revealed between the three response classes. That is, ACTH (day 1
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Table 5
DBF Means and Standard Deviations for Type x Drua x Day
< N - 60)
ja IZE® Drug Day M SD
8 A no drug 1 76.25 11.83
8 A no drug 2 72.00 8.28
20 A drug 1 76.20 10.93
20 A drug 2 75.60 8.45
10 B no drug 1 77.40 7.24
10 B no drug 2 79.00 8.60
22 B drug 1 76.27 10.15
22 B drug 2 77.54 10.79
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Table 6
HR Means and Standard Deviations for Type x Drug x Day 
( N - 60)
n Type Drug Day M SD
8 A no drug 1 68.50 7.54
8 A no drug 2 65.75 9.10
20 A drug 1 68.45 10.44
20 A drug 2 72.45 11.01
10 B no drug 1 72.60 6.99
10 B no drug 2 76.70 8.87
22 B drug 1 67.23 11.86
22 B drug 2 69.32 7.85
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Table 7
State Anxiety Means and Standard Deviations of Type x Drug x 
Day ( N - 60)
jn Type Prog Day M SD
8 A no drug 1 36.25 6.54
8 A no drug 2 32.25 7.40
20 A drug 1 36.80 10.89
20 A drug 2 35.10 9.01
10 B no drug 1 36.70 11.45
10 B no drug 2 34.20 10.81
22 B drug 1 34.90 9.31
22 B drug 2 33.36 9.10
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Table 8
TMD Means and Standard Deviations of Type x Drug a Day 
( N - 60)
ja Type Drug
8 A no drug
8 A no drug
20 A drug
20 A drug
10 B no drug
10 B no drug
22 B drug
22 B drug
Day M SD
1 150.50 32.74
2 148.62 33.96
1 149.15 28.01
2 140.05 27.25
1 149.90 26.70
2 147.60 20.22
1 150.27 36.98
2 144.86 31.00
Table 9
Pearson Correlation Matrix for all Dependent Variables 
ACTH1 SBP1 DBP1 HR1 Statel
ACTH1
THD1 ACTH2
SBP1 .08
DBP1 -.08 .63***
HR1 -.26 .11 .13
Statel .07 .00 -.03 .23
TM>1 .14 -.01 -.05 .22 .64***
ACTH2 .58*** -.02 ..03 -.22 .11 .14
SBP2 -.14 .49*** .36** .27* .17 .16 -.00
DBP2 ..09 .39** .50*** .27* .16 .24 -.09
HR2 -.32** .15 .21 .61*** .28* .21 -.20
State2 . 01 .12 -.03 .20 .59*** .50*** -.04
TMD2 .04 .06 -.02 .28* .55*** .70*** .07
*£ <.05, **p <.01, £  <.001
Mote. All slfnlflcance levels Mere obtained using tvo-tailed tests.
SBP2 0BP2 HR2 State2 TW2
.71***
.05 .19
.27* .16 .13
.19 .18 .27* .78***
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or day 2) did not correlate with any of the cardiovascular or 
psychological measures. Similarly, cardiovascular masures on day 
1 were not related to psychological measures on day 1. Two 
significant, but modest, correlations were revealed between 
cardiovascular and psychological measures on day 2. That is, 
state anxiety (day 2) was related to SBP (day 2). TMD (day 2) was 
modestly associated with HR (day 2). Regarding associations among 
dependent variables within the same classification, it was found 
that (a) both self-report measures (state anxiety and TMD) 
correlated highly with one another on day 1 and day 2; and (b) 
measures of SBP and DBP on day 1 and day 2 were highly related, 
but no significant correlations were revealed for HR. With 
respect to trait anxiety, significant correlations were revealed 
with state anxiety on day 1 and day 2 ( £  < .0001) and with TMD on 
day 1 and day 2 ( £  < .0001). No significant correlations for 
trait anxiety were noted among the biochemical measures or the 
cardiovascular measures.
CHAPTER POUR 
Discussion
The present stud/ was designed to investigate physiological 
and psychological reactivity to stress in JAS-assessed Type A and 
Type B cardiac patients. The evaluation of the effects of 
medications on the response to stress was also an integral goal of 
the current study. Briefly, and with regard to the full sanple ( 
N » 60), significant day main effects were revealed for ACTH,
SBP, and state anxiety. A significant main effect for drug and a 
significant Type x Drug interaction was found for ACTH. A 
significant Type x Day interaction was revealed for SBP. With 
regard to the extreme sanple ( N >30), significant main effects 
for day were found for state anxiety and HR. Because a different 
pattern of results were noted for the full sanple and the extreme 
sanple, these findings will be discussed separately.
Full Sample
It was hypothesized that all patients would perceive the 
catheterization day (day 1) to be more stressful than the 
post-catheterization day (day 2). The main effects for day, found 
for ACTH, SBP, and state anxiety, provide support for this 
hypothesis. Patients, as a group, did respond to day 1 with 
higher levels of ACTH, SBP, and anxiety ratings as ccnpared to day 
2. Although the mean differences between day 1 and day 2 on these 
three measures were relatively small, the sanple size used in the 
present study suggests that these differences were inportant and 
noteworthy. The data indicate, then, that the cardiac
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catheterization did serve as a significantly stressful event for 
the subjects.
It was predicted that Type As, as compared to Type Bs, would 
exhibit greater responsiveness to the catheterization procedure. 
This hypothesis was not supported in the present study. This 
failure to find differences between Type A and Type B subjects is 
inconsistent with much of past research (e.g., Kahn et al., 1980; 
Corse et al., 1982; and Krantz et al., 1982). Consistent with the 
present results are those studies from which negative findings 
have been published (e.g., Steptoe et al., 1981; Case et al.,
1985). A number of possibilities exist for this failure to find 
A-B differences. First, there is some evidence to suggest that 
age nay be an important factor in reactivity to stress (Houston & 
Ewart, 1984; Watkins & Eaker, 1986). The research in this area is 
controversial but most of the available data indicates that, with 
increasing age, there is decreasing sensitivity to beta-adrenergic 
stimulation. This data would imply that, for at least 
cardiovasular measures of reactivity, older individuals may appear 
less responsive to stress. The association between ACTH and age 
is more speculative. Because the size of the pituitary decreases 
with age, there may be a correlation between inceasing age and 
decreasing ACTH secretion (Daughaday, 1981). The sample used in 
the current study was comprised largely of older individuals ( M 
= 53 years). The use of an older population may have restricted 
the range of responses to the stressor. It is possible that a 
younger sample may have exhibited more pronounced A-B differences.
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This would imply, as has been reccnraended recently in the 
literature, that age factors should be more closely examined in 
future reactivity research (Houston et al., 1984; Watkins et al.,
1986).
A second possible source of influence in the current data set 
involves the effects that drugs (i.e., beta-blockers, 
calcium-channel blockers, and both of these) had on the response 
to the stressor. The use of these drugs were associated with 
lower ACTH responses in Type A individuals to levels consistent 
with those shown by Type B subjects. Because the greater 
proportion of the study subjects were taking these target drugs, 
it is possible that these drugs may also have restricted the range 
of possible stress responses and/or served to further mask the 
differences between Type As and Type Bs. It should also be noted 
that the effects of some drugs (e.g., nitrates) were not 
systematically controlled. It is possible that the effects of 
uncontrolled medications also affected the current findings. The 
finding that drugs were associated with significantly reduced 
responsiveness to the stressor strongly suggests that future 
reactivity research control for these effects.
The failure in the current study to use extreme behavior 
types may also have contributed to the lack of A-B differences. 
There has been seme suggestion in the literature (Krantz et al., 
1984) that extreme Type As are more reactive to stress than 
non-extreme Type A individuals. The majority of this research has 
been shown with the Structured Interview. The use of extreme
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scores may be necessary to obtain more salient differences between 
Type A and Type B subjects. An attempt was made to explore this 
possibility in the current study by conducting an additional 
analysis of the dependent measures of those subjects scoring in 
the extreme Type A and B range. The failure to find significant 
A-B differences in this case may have resulted fran the small 
sample that was used ( N » 30).
One final area of concern with respect to reasons for failing 
to identify significant A-B differences involves those patients 
who refused to participate in the study. These patients, 
approximately 15-20 in number, refused to participate for reasons 
that, on an unsystematic observation, appeared anxiety-related 
(e.g., fear of needles, too much to deal with during 
hospitalization, too much paperwork, etc). The inability to 
include these patients, fran whose verbal behavior one might 
speculate anxiety and/or time urgency, may have also restricted 
the range of responses to the stressor. That is, Type As, 
because of their impatient nature, may have been less willing to 
participate in a time-consuning study. This would hold especially 
true for extreme Type As that would be expected to harbor the most 
intense feelings of time urgency. Future research aimed at 
investigating individuals who refuse to participate in studies 
would be helpful in determining posssible biases in study 
populations.
The speculation that medications may have served to restrict 
the range of responsiveness in the current study is indirectly
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supported by the findings of a significant drug effect and Type x 
Drug interaction for ACTH. Consistent with previous literature 
(Durel et al., 1985), beta-blockers, calcium-channel blockers, and 
both, were associated with reduced responsivity to the stressor in 
all subjects (drug main effect). Moreover, the significant Type 
x Drug interaction for ACIH indicated that the target drugs 
differentially affected Type A and Type B subjects as was 
predicted in the hypotheses. Type As in the no drug condition of 
the independent variable of drug group were more reactive (i.e., 
greater concentrations of ACIH) to the stressor than were Type As 
in the drug condition. The use of the target medications appeared 
to have less of an inpact on Type Bs subjects because ACTH 
concentrations were similar regardless of the drug condition 
(i.e., drug or no drug). These data suggest, then, that the 
target drugs were more effective for Type A subjects. It should 
be noted that two inportant points make specific comparisons of 
the current data to past research findings difficult. First, 
previous research on the effects of pharmacologic interventions on 
stress have typically studied one drug at the time. The current 
study compared the effects of beta-blockers, calcium-channel 
blockers, and both of these combined to a group of patients taking 
neither of these drugs. Second, previous Type A reactivity 
research has, without question, neglected the investigation of 
ACIH. Given these considerations, it is difficult to compare the 
current findings with those of previous research. Nonetheless, 
these results, suggesting that ACTH reactivity to stress can be
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reduced pharmacologically, can be considered as breaking new 
ground for future research. Seme degree of caution is necessary 
in interpreting these results until future replications are 
conducted. However, the nature of the sample size ( N * 48) and 
the degree of significance ( £  < .003) for the Type x Drug 
interaction would suggest that these results do not reflect 
spurious findings.
Several important research and clinical implications can be 
drawn from the drug main effect and the Type x Drug interaction 
obtained for ACIH. First from the standpoint of research, the 
current data suggest that the control and evaluation of the 
effects of various medications upon reactivity is necessary in 
future research. It is possible/ based on the current data, that 
recent studies failing to find A-B differences (e.g., Komfeld et 
al., 1985) may have resulted from an inadequate investigation of 
drug effects. From a clinical perspective, several implications 
can be drawn from the current study. One of the more exciting 
areas of recent Type A research involves the hypothesis that 
beta-blockers effectively modify Type A behavior to that more 
consistent with Type B behavior patterns (Durel et al., 1985).
The current study provides indirect support for this hypothesis in 
that drugs had the effect of reducing the responsivity of the Type 
A subjects to that exhibited by Type B subjects. Further, if one 
accepts the evidence that Type A behavior is associated with an 
increased risk of coronary heart disease, then the use of drugs 
that could modify Type A behavior may decrease Type A related CHD
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risk. There is evidence from the research of Brand et al. (1976) 
that a 31 per cent reduction of CHD risk would would occur if the 
direct risk associated with Type A were eliminated. Therefore, 
the use of beta-blockers, given continued supportive research, may 
make a valuable contribution to reducing CHD. Knowledge that 
certain medications can substantially reduce the Type A 
individuals' response to a stressful situation (e.g., surgery) 
would also be useful information to the physician. This knowledge 
would be particularly beneficial if the stressor carried with it 
dangerous side effects (eg., coronary artery bypass grafting). In 
situations such a major surgery, the use of medications to reduce 
anxiety may lead to a lesser incidence of post-operative 
complications. Investigations of the combined efficacy of drugs 
and well-known psychological methods of anxiety management could 
be another avenue for research.
A significant Type x Day interaction was also found for SBP. 
Inconsistent with previous research (Krantz et al., 1982;
Dembroski et al., 1977) and with the current hypotheses, SBP of 
Type A subjects did not differ fran Type B subjects when exposed 
to the stressor (day 1). It is possible that the use of drugs in 
the greater majority of patients served to restict the range of 
SBP responsiveness to the stresses:. Inconsistencies with previous 
research (Jennings et al., 1984, Friedman et al., 1960) and the 
current hypotheses were also found for SBP on day 2. Research 
would suggest that Type As and Bs should be similar during periods 
of rest. This was not supported by the current data. It is
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unclear why Type A subjects, as ccnpared to Type B subjects, 
demonstrated lower levels of SBP on day 2.
Extreme Sample
A very different pattern of results was observed using the 
extreme sample. In fact, the only significant findings for this 
sample were day effects for state anxiety and HR. No main effects 
for behavior type were revealed. This is inconsistent with 
previous findings that extreme type As are more reactive to stress 
than their non-extreme Type A counterparts (Krantz et al., 1984). 
Two points should be noted regarding this analyses. First, it was 
not possible to investigate medications in this analysis. As has 
been suggested previously, the failure to investigate the effects 
of medications may obscure A-B differences. Second, extreme Type 
As and Bs in the current study were identified in a slightly 
different manner than is typically used in the current literature. 
Typically, extreme scorers*are those falling one standard 
deviation above (extreme Type A) or below (extreme Type B) the 
mean on the Overall Type A score of the JAS. Upper and lower 
quartiles were used in the present study. Whether or not this 
modest difference in identifying extreme scorers accounted for the 
lack of significant A-B differences is unknown and remains a 
question for future research. It should be noted, however, that 
obtaining large sample sizes of extreme subjects is rather 
problematic for the researcher interested in this area. 
Correlational Data
A review of the Pearson correlation matrix suggests several
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points. First, the correlation of each dependent variable with 
itself (e.g., ACTH on day 1 correlated with ACTH on day 2) was 
highly significant suggesting stability of each dependent measure 
across both days of measurement. As has been suggested, the use 
of medications may have served to provide a ceiling effect on 
arousal. More importantly, perhaps, were the lack of significant 
correlations among the biochemical, cardiovascular, and 
self-report measures of arousal. The lack of correlation among 
different response channels of anxiety (i.e., physiological, 
self-report, and motoric responses) is a reliable finding in the 
anxiety literature (Neitzel & Bernstein, 1981). Termed "response 
desynchrony," the lack of correlation among response channels of 
anxiety is thought to occur because the display of anxiety is a 
result not only of the eliciting stimulus but of other factors as 
well. For example, in the present study, it is likely that, 
although a subject may have felt subjective distress as a result 
of the impending catheterization, the distress may not have been 
reflected in the self-report measures because the subject may not 
have wanted to appear distressed to the experimenter. There was 
also a lack of correlation among the physiological measures. 
Although SBP and DBP were significantly associated with one 
another, neither were found to be associated with HR. These 
findings are consistent with previous research as it is not 
unccnmon for different physiological masures to correlate poorly 
with one another (Lacey, 1967). The occurrence of desynchrony 
among response channels as well as within channels has number of
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indications. First, the investigation of anxiety or arousal 
requires multiple assessment methods. Second, it is probably best 
to avoid statistical methods of analysis that assume 
intercorelations among dependent variables (e.g., multivariate 
approaches).
Summary and Future Directions
The major contribution of the current study was the finding 
that medications (i.e., beta-blockers, calciun-channel blockers, 
and both combined) were associated with significantly reduced 
responsivity to stress in Type A cardiac patients. The 
implications of this finding were discussed and the continued 
control for and evaluation of the effects of medications upon 
reactivity was emphasized.
Based on the current results, a number of future research 
directions are inplicated. First, systematic investigation 
regarding the influence of age upon reactivity would be useful. 
Second, a more thorough analysis of the effects of various drug 
groups (e.g., beta-blockers, calcium channel blockers, nitrates) 
upon reactivity is necessary before definitive statements can be 
made. Finally, future reactivity research is likely to benefit 
from more frequent sampling of dependent measures, particularly 
when endocrinological responses are assessed.
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Appendix A
INFORMED CONSENT AGREEMENT
I, ________________ » do hereby consent to participate in
the study entitled "The Type A Behavior Pattern and ACTH 
Response to the Stress of Cardiac Catheterization"* the 
purpose of which is to investigate how different individuals 
respond to cardiac catheterization* I understand that I have 
been scheduled for cardiac catheterization on the advice of my 
physician and that I am not being catheterized because of my
participation in the study* As such I will be signing a
separate consent agreement to undergo cardiac catheterization. 
Other than procedures to be described below* my treatment 
while hospitalized will be identical to that of any patient 
hospitalized for cardiac catheterization.
Ms. Marie Veltia* M.S., psychology Intern under the 
supervision of Dr. John Roitzsch* has explained to me verbally 
the procedures* as described below* and I fully understand the 
following:
A. Procedure
1. Upon my consent to participate in the study* I will 
be asked to complete a Personal Information Form which will 
ask for demographic information (age* education, occupation) 
and for information about the presence of traditional risk 
factors (smoking history* family history of cardiovascular 
disease* etc.).
2. I agree to complete the following questionnaires at
the times designated below. I understand that Ms. Veitia will
show me these forms as they are described.
a) Activity Survey (to be completed the evening before the 
cathe terlzation
b) Anxiety Inventory (to be completed the morning prior to 
catheterization and the morning after
c) Mood Inventory (to be completed the morning prior to 
catheterization and the morning after)
All of these questionnaires are brief* each requiring 10-15 
minutes or less to complete.
3) 1 agree to allow trained nursing personnel to draw
blood with a needle from a vein in my arm on two occasions- 
the morning prior to catheterization and the morning after. 
Approximately 10 cc (about two teaspoonfuls) of blood will be 
drawn during each of the two blood drawing times. This blood 
will be analyzed for chemicals (hormones) that occur during 
stress.
4) I agree to allow Ms. Veltia to examine my medical 
record to obtain other pertinent information (for example* 
vital signs such as blood pressure and heart rate).
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B. Duration : Upon my discharge from HUH, my participation
in the study will be completed.
C. Possible Discomforts and/or Risks : The procedure to be 
followed in the study are standard and non-experimental. When 
blood is drawn from my arm, I may feel a slight pain and the 
spot from which the blood is taken may be temporarily bruised. 
There is a slight chance of inflammation of the vein and/or a 
blood clot formation, but this is extremely rare. There are 
no risks associated with taking the psychological 
questionnaires included in the study. I understand that there 
are risks associated with the cardiac catherization and these 
will be explained to me on a separate consent agreement to 
undergo this procedure, since undergoing the catheterization 
itself has been scheduled for medical reasons and not for 
purposes of this study.
D. Possible Benefits : I understand that the study may not
benefit me directly, but will help scientists obtain new 
knowledge that may benefit patients in the future. 1 
understand that, if desired, an interpretation of my 
psychological testing will be made available to me upon 
completion of the study. If I would like appropriate referral 
, this will be made available to me.
Ms. Marie Veltia has agreed to answer any inquiries that 1 may 
have concerning the procedures and has informed me that I may 
also contact the Medical Unlveraity of South Carolina 
Institutional Review Board for Human Research (803/792-4148) 
directly concerning patient rights. This board administers 
the agreement with the United States Department of Health and 
Human Services covering the protection of human subjects.
I understand that in the event of any injury resulting from 
the research procedures to the participant, reasonable 
medical treatment not otherwise covered by third party 
payments will be available free through the Medical 
University; financial compensation is not available for 
medical treatment elsewhere, loss of work, or other expenses.
I may contact the Medical University of S.C. Hospital Medical 
Director(803/792-3932) concerning medical treatment.
I understand that the participant's records of participation 
in this study are not accessible to the general public and 
confidentiality will be maintained. Information that may be 
gained from this study will be used only for research and 
educational purposes. Information may be published with the 
permission of the principal investigator in medical journals, 
but the participant's identity will not be revealed. However, 
identifying information will be available to monitors from the 
MUSC I.R.B. for Human Research and the U.S. Food and Drug 
Administration.
It is understood that participation is totally voluntary, and 
I may choose not to participate. I also understand that I am 
free to withdraw my consent and discontinue participation at 
any time. Discontinuation will in no way jeopardise the 
participant*8 ability to receive treatment now or in the 
future at this institution.
I will receive a copy of the informed consent after it has 
been read, understood, and signed.
DOCTOR OBTAINING CONSENT SIGNATURE OF
PARTICIPANT
WITNESS WITNESS
DATE OF CONSENT SIGNATURE OF LEGAL
GAURDIAN
(if applicable)
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Appendix B 
PERSONAL INFORMATION FORM
N A M E _________
DATE OF BIRTH
EDUCATION: ____ DID NOT GRADUATE HIGH SCHOOL
  GRADUATED HIGH SCHOOL
  COMPLETED TRADE SCHOOL
  SOME COLLEGE ____ NO. OF YEARS
  GRADUATED FROM FOUR YEAR COLLEGE
  POSTGRADUATE WORK ____ HIGHEST DEGREE
CURRENT EMPLOYMENT STATUS:
  FULL TIME
 PART TIME  HOURS PER WEEK
  UNEMPLOYED
 RETIRED   YEAR
 DISABLED  YEAR
DESCRIPTION OF PRESENT JOB:
Job Title _ _ _ _ _ _ _ _  No. of years _ Average
hours per week ___
ACTIVITY LEVEL: Which category listed below best describes
your current activity?   Which best describes your
activity in the past year?
1. Active: An athlete in training or a person who exercises 
at a level comparable to running at least 10 miles per week or 
a job involving heavy manual labor.
2. Moderately Active: Planned recreation, such as running,
swimming, bicycling, at least three days a week or a job 
involving moderate activity, such as construction work or 
farming.
3. Light Activity: Gardening, fishing, walking a mile most
days, or a job Involving walking or frequent step climbing.
4. Sedentary: Only normal daily activities such as eating, 
sleeping, sitting, talking, attending school, or a sedentery 
job.
SMOKING HISTORY: Do you smoke now (cigarettes, pipe, cigars)?
Yes, No
If cigarettes, how many packs per day? ____
Total number of years smoked? ____
FAMILY HISTORY: Does anyone in your family have (or had)
heart disease?  Whom? Has anyone
in your family ever died of heart disease? __ At what age or
ages?
DATE ___________________
HEIGHT _____ WEIGHT
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ADDITIONAL RISK FACTORS:
  High blood pressure
  Diabetes
  High dietary intake of fat
_____ High cholesterol or triglycerides 
  previous heart attack
WHAT ARE YODR CURRENT MEDICATIONS? DOSAGE FOR HOW LONG? 
^circle as many aa apply)
NITRATES AND NITROGLYCERINS 
Cardilate (oral)
Diltrate (oral)
Nitrong (oral)
NitroBid (oral)
Nitroglyn (oral)
Isordll (oral)
Sorbide (oral)
IsoBid (oral)
Duotrate (oral)
Pentritol (oral)
Peritrate (oral)
Ntrospan (oral)
Trldll (oral)
Cardabid (oral)
Nltrol Ointment 
NitroBid Ointment 
Nltrostat Ointment 
Nitrong Ointment 
Nitrodiac (transdermal)
Nitro-Dur (transdermal)
Transderm NTG (transderm)
Susadrin Tranamucosal tabs
BETA-BLOCKERS
Inderal (Propanolol HCL)
Vlsken (Pindolol)
Blockadren (Timolol maleate)
Corgard (Nadolol)
Lopressor (Metropolol)
Tenormin (Atenolol)
CALCIUM ENTRY BLOCKERS 
Procardia (Nifedipine)
Iaoptln (Verapamil)
Calan (Verapamil)
Cardizem (Diltiazem HCL)
OTHERS:(Including psychiatric meds):
REASON FOR HEART CATH?
HATE YOU EVER HAD A HEART CATH BEFORE? Y OR N If so, when?
HAVE YOU EVER HAD A CORONARY ARTERY BYPASS? Y OR N If so, 
when?
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Appendix C
Appendix Cl’ ACTH statistical Summary Table for 2 x 2 x 2  ANOVA 
with Repeated Measures on Day { N - 48)
Appendix C2t SBP Statistical Summary Table for 2 x 2 x 2  ANOVA 
with Repeated Measures on Day ( N = 60)
Appendix C3: DBP Statistical Suntnary Table for 2 x 2 x 2  ANOVA
with Repeated Measures on Day ( N * 60)
Appendix C4; HR Statistical Sunmary Table for 2 x 2 x 2  ANOVA 
with Repeated Measures on Day ( N ■ 60)
Appendix C5: State Anxiety Statistical Sunmary Table for 2 x 2 x 
2 ANOVA with Repeated Measures on Day ( N = 60)
Appendix C6s TMD Statistical Sunmary Table for 2 x 2 x 2  ANOVA 
with Repeated Measures on Day ( N - 60)
116
Appendix Cl
ACTH Statistical Sunmary Table for 2 x 2 x 2  (Behavior Type x Drug
Group x Day) ANCWA with Repeated Measures on Day ( N - 48)
Source df MS F £
Type 1 2059.21 2.20 .14
Drug 1 4136.15 4.42 .04
Type x Drug 1 9003.73 9.63 .003
Day 1 2005.15 6.38 .01
Type x Day 1 747.91 2.38 .13
Drug x Day 1 117.39 0,37 .54
Type x Drug x Day 1 447.53 1.42 .24
S s (Type x Drug) 44 935.99
Day x S s (Type x Drug) 44 314.16
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Appendix C2
SEP Statistical Sunmary Table for 2 x 2 x 2  (Behavior Type x Drug
Group x Day) ANCVA with Repeated Measures on Day ( N ■ 60)
Source df MS P E
Type 1 234.57 0.56 .46
Drug 1 60.09 0.14 .71
Type x Drug 1 6.45 0.01 .91
Day 1 628.48 4.51 .04
Type x Day 1 890.77 6.39 .01
Drug x Day 1 43.55 0.31 .58
Type x Drug x Day 1 392.54 2.82 .10
S s (Type x Drug) 56 436.65
Day x S s (Type x Drug) 56 139.42
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Appendix C3
DBP Statistical Summary Table for 2 x 2 x 2  (Behavior Type x Drug
Group x Day) ANOVA with Repeated Measures on Day ( N - 60)
Source df
Type 1
Drug 1
Type x Drug 1
Day 1
Type x Day 1
Drug x Day 1
Type x Drug x Day 1
S s (Type x Drug) 56
Day x s s (Type x Drug) 56
MS £  E
159.26 1.09 .30
1.34 0.01 .92
58.66 0.40 .53
5.72 0.12 .73
92.36 1.94 .17
16.97 0.36 .55
24.68 0.52 .47
145.79 
47.70
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Appendix C4
HR Statistical Suanary Table for 2 x 2 x 2  (Behavior Type x Drug
Group x Day) ANOVA with Repeated Measures on Day ( N =60)
Source df MS F £
Type 1 163.41 1.06 .31
Drug 1 60.77 0.39 .53
Type x Drug 1 587.50 3.80 .06
Day 1 89.60 2.39 .13
Type x Day 1 34.96 0.93 .34
Drug x Day 1 34.23 0.91 .34
Type x Drug x Day 1 119.71 3.20 .08
S s (Type x Drug) 56 154.08
Day x S s (Type x Drug) 56 37.43
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Appendix C5
State Anxiety Statistical Suimary Table for 2 x 2 x 2  (Behavior 
Type x Drug Group x Day) ANOVA with Repeated Measures on Day ( N 
= 60)
Source df MS F £
Type 1 3.17 0.02 .88
Drug 1 0.83 0.01 .94
Type x Drug 1 56.68 0.39 .53
Day 1 148.23 3.97 .05
Type x Day 1 4.16 0.11 .74
Drug x Day 1 16.45 0.44 .51
Type x Drug x Day 1 2.82 0.08 .78
S s (Type x Drug) 56 146.10
Day x S s (Type x Drug) 56 37.38
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IMP Statistical Summary Table for 2 x 2 x 2  (Behavior Type x Drug
Group x Day) ANCWA with Repeated Measures on Day ( N = 60)
Source df MS
Type 1 32.90
Drug 1 233.92
Type x Drug 1 89.21
Day X 556.90
Type x Day 1 18.35
Drug x Day 1 165.92
Type x Drug x Day 1 26.43
S s (Type x Drug) 56 1575.74
Day x S s (Type x Drug) 56 274.25
P
0.02
0.15
0.06
2.03
0.07
0.61
0.10
£
.88
.70
.81
.16
.80
.44
.76
Appendix D
Appendix Dl: ACTH Statistical Sunmary Table for 2 x 2  ANOVA with
Repeated Measures on Day { N = 22)
Appendix D2: SBP Statistical Sunmary Table for 2 x 2  ANOVA
with Repeated Measures on Day ( N * 30)
Appendix D3: DBP Statistical Sunmary Table for 2 x 2  ANOVA with
Repeated Measures on Day ( N = 30)
Appendix D4: HR Statistical Summary Table for 2 x 2  ANOVA with
Repeated Measures on Day ( N * 30)
Appendix D5: State Anxiety Statistical Sunmary Table for 2 x 2
ANOVA with Repeated Measures on Day ( N = 30)
Appendix D6: TMD Statistical Sunmary Table for 2 x 2  ANOVA with 
Repeated Measures on Day ( N * 30)
12.2
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Appendix D1
ACIH Statistical Santary Table for 2 x 2  (Behavior Type x Day)
ANOVA with Repeated Measures on Day ( N ■ 22)
Source df . MS I £
Type 1 5.24 0.01 .94
Day 1 280.18 0.75 .40
Type x Day 1 278.20 0.74 .40
S s x Day (Type) 20 374.99
Appendix D2
SBP Statistical Stannary Table for 2 x 2  (Behavior Type x Day)
ANOVA with Repeated Measures on Day ( N = 30)
Source df MS F £
Type 1 928.27 2.66 .11
Day 1 224.27 1.77 .19
Type x Day 1 317.40 2.51
Day x S s (Type) 28 126.37
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Appendix D3
DBP Statistical Sunmary Table for 2 x 2  (Behavior Type x Day)
ANCWA with Repeated Measures on Day ( N * 30)
MS F £
147.27 1.26 .27
24.07 0.55 .47
19.27 0.44 .51
43.67
Source df
Type 1
Day 1
Type x Day 1
Day x £  s (Type) 28
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Appendix D4
HR Statistical Summary Table for 2 x 2  (Behavior Type x Day) ANOVA 
with Repeated Measures on Day ( N =30)
Source df MS F £
Type 1 60.00 0.39 .54
Day 1 166.67 4.30 .05
Type x Day 1 60.00 1.55 .22
Day x S s (Type) 28 38.76
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Appendix D5
State Anxiety Statistical Suwnary Table for 2 x 2  (Behavior Type x
Day) ANOVA with Repeated Measures on Day ( N = 30)
Source df MS F £
Type 1 96.27 0.76 .39
Day 1 153.60 4.07 .05
Type x Day 1 0.60 0.02 .90
Day x S s (Type) 28 37.74
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Appendix D6
TOD Statistical Suimary Table for 2 x 2  (Behavior Type x Day)
ANOVA with Repeated Measures on Day ( N * 30)
Source df MS £  £
Type 1 64.07 0.04 .84
Day 1 405.60
Type x Day 1 395.27
Day x S s (Type) 28 141.90
2.86 .10
2.79 .11
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